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Abstract 
 
Selenocysteine (Sec) is the 21st amino acid. Unlike other amino acids incorporation of Sec 
into proteins is more complex by far as it is encoded by the opal stop codon UGA. A complex 
and highly sophisticated incorporation mechanism is required in order to assure the correct 
co-translational incorporation of Sec into the nascent polypeptide chain. Even after years of 
intensive research the question as to why selenoproteins are important for mammalian life 
has not been fully understood. This study aimed to provide answers to this question using 
gluthathione peroxidase 4 (GPx4) as a model enzyme. It has been shown that GPx4 is 
essential for early embryogenesis, neuro- and retina-protection and male fertility in mice. But 
the role of selenothiol- versus thiol-based GPx4 catalysis in cells and mice, as well as the 
role of the catalytic tetrad in GPx4 catalysis and the subcellular localisation of the different 
GPx4 isoforms and their impact on cell protection have remained unclear. Therefore, a series 
of mutant variants of GPx4 were generated by site-directed mutagenesis, stably expressed in 
tamoxifen-inducible GPx4 knockout cells (Seiler et al., Cell Metab 2008), and functionally 
analysed. GPx4 mutant variants included those of the peroxidatic Sec, the catalytic tetrad, 
the mitochondrial leader sequence (Mls) and the non-peroxidatic cysteines. These studies 
revealed that Cys can functionally replace Sec in the active centre of GPx4 to a large extent 
in cells, whereas some amino acids of the catalytic site are necessary for GPx4 function. 
None of the non-peroxidatic Cys were shown to be required for the cell-protective function of 
GPx4, ruling out a possible resolving Cys in the catalytic cycle of GPx4 unlike homologues in 
other organisms that use a resolving Cys. The fuction of a resolving Cys is to start a 
nucleophilic attack upon the intermolecular bond between the peroxidatic Cys and the 
substrate in order to create an intramolecular disulfidbride. Apparently subcellular localisation 
of GPx4 in the extramitochondrial/cytosolic compartment is crucial for its cell death 
preventing qualities as overexpression of mitochondrial GPx4 in the knockout cells failed to 
rescue cell death induced by endogenous GPx4 disruption.  
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Zusammenfassung 
 
Bei Selenocystein (Sec) handelt es sich um die 21igste Aminosäure. Im Gegensatz zu 
anderen Aminosäuren ist der Einbau von Selenocystein in die entstehende Polypeptidkette 
sehr viel komplexer, da Sec von dem Opal Stopcodon UGA codiert wird. Eine komplexe und 
hochentwickelte Maschinerie ist erforderlich um den korrekten, ko-translationalen Einbau von 
Sec in Proteine zu gewährleisten. Auch nach Jahren intensiver Forschung ist es immer noch 
weitgehend unklar, warum Selenoproteine für das Säugerleben unverzichtbar sind. Diese 
Studie hatte deshalb zum Ziel, diese Frage etwas genauer zu beleuchten, wobei die 
Glutathion-Peroxidase 4 (GPx4) als Modellenzym verwendet wurde. Es ist bekannt, dass 
GPx4 sowohl für die Embryonalentwicklung, den Schutz von Neuronen und der Retina sowie 
für die männliche Fertilität von Mäusen unverzichtbar ist. Dennoch sind viele Fragen 
bezüglich der Funktionsweise und möglicher Unterschiede von Selenothiol- zu Thiol-
basierter GPx4 Katalyse in Zellen und Mäusen ungeklärt. Ebenso wie die genaue Funktion 
der katalytischen Tetrade bei der GPx4 Katalyse, und die subzellulare Lokalisation der 
verschiedenen GPx4 Isoformen und deren Einfluß auf den zellulären Schutz bislang 
ungeklärt sind. Deswegen wurden in dieser Arbeit eine Reihe von GPx4 Mutanten durch 
zielgerichtete Mutagenese erzeugt. Diese wurden stabil in Tamoxifen-induzierbaren GPx4 
knockout Zellen (Seiler et al., Cell Metab 2008) exprimiert und auf ihre Funktionalität 
analysiert. Die verschiedenen GPx4 Mutationen beinhalteten Mutanten des Sec im aktiven 
Zentrum, der katalytischen Tetrade, der mitochondrialen Signalsequenz (Mls) sowie der nicht 
peroxidativen Cysteine. Die hier vorgelegten Untersuchungen zeigen, dass Cys in der Lage 
ist das Sec im aktiven Zentrum, unter Aufrechterhaltung eines Großteils der Funktionalität, in 
der Zelle zu ersetzen, wohingegen einige der Aminosäuren der katalytischen Tetrade 
unentbehrlich für die Funktionalität von GPx4 sind. Keines der übrigen, in GPx4 
vorhandenen, Cys wurde benötigt, um die zelluläre Schutzwirkung von GPx4 aufrecht zu 
erhalten. Dieses Ergebnis schließt die Existenz eines auflösenden Cys im katalytischen 
Kreislauf von GPx4 aus. Dies steht im Gegensatz zu den Cys tragenden Homologen in 
anderen Organismen, welche über ein auflösendes Cys verfügen. Die Funktion des 
auflösenden Cys besteht darin, einen nukleophilen Angriff auf die intermolekulare Bindung 
zwischen dem peroxidativen Cys und dem Substrat zu starten. Durch diesen Angriff wird die 
intermolekulare Bindung in eine intramulekulare Disulfidbrücke umgewandelt. Die 
Lokalisation von GPx4 im extramitochondrialen/cytosolischen Raum ist zudem entscheidend 
für den Schutz vor Zelltod, da eine Überexpression der mitochondrialen GPx4 nicht in der 
Lage war, den durch Ausschalten der endogenen GPx4 verursachten Zelltod zu verhindern.  
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1 Introduction 
 
1.1 Selenoproteins 
 
The trace element Selenium (Se) is important for some eubacteria, archaea and eukaryotes. 
In these organisms, Se is mainly found being incorporated into the 21st amino acid, 
selenocysteine (Sec). Sec differs from cysteine (Cys) only in one atom, selenium replacing 
sulphur. Sec is co-translationally inserted into Sec-containing proteins, also called 
selenoproteins. In general Sec is mostly part of the reactive centre and essential for enzyme 
function (Lu and Holmgren 2009, Steinbrenner and Sies 2009). The widely accepted concept 
implies that Sec comprises a higher reactivity than its sulphur containing analogue Cys 
presumably due to a higher nucleophilicity and the ability to be already deprotonated under 
physiological pH (Gromer, Johansson et al. 2003). Sec is also suggested to allow for a 
broader range of substrates (Gromer, Johansson et al. 2003).  
Selenoproteins are expressed in multiple organisms, including eubacteria, archaea, insects, 
vertebrates and humans (Lobanov, Hatfield et al. 2009). By contrast, yeast and plants lack 
selenoproteins, implying that the presence of selenoproteins follows neither a uniform 
distribution within different organisms nor any correlation between selenoprotein utilisation 
and increasing complexity of the organism. Likewise, questions have remained unanswered, 
concerning why mammals require selenoprotein expression for proper embryonic 
development (Bosl, Takaku et al. 1997, Kumaraswamy, Carlson et al. 2003), whereas other 
species, which lack selenoproteins, such as Drosophila Melanogaster (Drosophila), only 
express the respective cysteine containing homologue (Hirosawa-Takamori, Chung et al. 
2004). Screening of aquatic organisms’ genomes suggested that selenoprotein expression 
may be linked with the environment, as a higher number of selenoproteins could be found in 
aquatic organisms when compared to terrestrial organisms (Lobanov, Fomenko et al. 2007, 
Arner 2010).  
Site-directed mutagenesis of Sec to Cys or chemical derivatisation of Sec in various 
selenoproteins, including glutathione peroxidases (Maiorino, Aumann et al. 1995) and 
thioredoxin reductases (Lee, Bar-Noy et al. 2000, Zhong, Arner et al. 2000) revealed a 
remarkable drop of enzyme activity. The reasons for the advantage of Sec- versus Cys-
based catalysis are still not fully understood, although some interesting concepts have been 
developed in case of human thioredoxin reductase (TR1) (see chapter 1.2) (Gromer, 
Johansson et al. 2003).  
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In contrast to the other 20 amino acids encoded by the universal genetic code Sec is 
encoded by the opal stop codon (UGA). Sec incorporation requires unusual rearrangements 
for correct incorporation during translation (Chambers, Frampton et al. 1986, Zinoni, 
Birkmann et al. 1986) (see chapter 1.3). Initially, the misinterpretation of UGA codons as 
simple translational STOP codons precluded the correct identification of proteins as true 
selenoproteins in many organisms.  
Glutathione peroxidase 1 (GPx1) was the first mammalian selenoenzyme to be discovered 
by two independent groups in 1973 (Flohe, Gunzler et al. 1973, Rotruck, Pope et al. 1973). 
Eventually it was revealed that mice express 24 and men 25 selenoproteins, respectively 
(Kryukov, Castellano et al. 2003). GPx6 is the only exception, which is a Cys containing 
variant in mouse and a selenoprotein in human. Simultaneous disruption of all selenoproteins 
in the mouse, achieved by targeted deletion of the Sec-specific tRNA gene (Trsp), causes 
early embryonic death at E6.5 (Bosl, Takaku et al. 1997). So far knockout studies for 
individual selenoproteins revealed, that only cytosolic thioredoxin reductase (Jakupoglu, 
Przemeck et al. 2005), mitochondrial thioredoxin reductase (Conrad, Jakupoglu et al. 2004) 
and GPx4 are essential for murine development (Conrad 2009). Since GPx4-/- mice die 
almost as early as Trsp null mice (Bosl, Takaku et al. 1997), it is reasonable to conclude that 
GPx4 is a vitally important selenoprotein in mammals. 
Human selenoprotein families relevant for this work are summarized in Table 1 (Kryukov, 
Castellano et al. 2003). 
 
Table 1: Relevant selenoprotein families.   
Abbreviations: Glutathione peroxidases (GPxs), and thioredoxin reductases (TrxRs) are clustered into distinct 
protein families. Due to its relevance for this work, GPx4 (PHGPx) is highlighted in red (adopted and modified 
from (Kryukov, Castellano et al. 2003)). 
 
Name 
Chromosomal 
location 
(number of exons) 
Main catalytic function  
Sec location in 
protein 
(length aa chain) 
GPx1 3p21.31 (2) H2O2 + 2 GSH -> 2H2O + GSSG 47 (201) 
GPx2 14q23.3 (2) H2O2 + 2 GSH -> 2H2O + GSSG 40 (190) 
GPx3 5q33.1 (5) H2O2 + 2 GSH -> 2H2O + GSSG 73 (226) 
GPx4 19p13.3 (7) ROOH + 2 GSH -> H2O + GSSG + 
ROH 
73 (197) (long form) 
46 (170) (short form) 
GPx6 6p22.1 (5) H2O2 + 2 GSH -> 2H2O + GSSG 73 (221) 
TrxR1 12q23.3 (15) Trx-S2 + NADPH + H
+
 -> Trx-(SH)2 + 
NADP+ 
498 (499) 
TrxR2 3q21.2 (16) Trx-S2 + NADPH + H
+
 -> Trx-(SH)2 + 
NADP+ 
655 (656) 
TrxR3 22q11.21 (18) Trx-S2 + NADPH + H
+
 -> Trx-(SH)2 + 
NADP+ 
522 (523) 
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Results obtained by overexpression of individual selenoproteins or by Se depletion/repletion 
studies in rodents must be interpreted carefully (Weitzel, Ursini et al. 1990). Changes in 
availability of cellular Se is known to have a significant influence on the expression of specific 
selenoproteins, which has been described as the “hierarchy” of selenoprotein expression 
(Schomburg and Schweizer 2009). This hierarchy has been thoroughly investigated for 
members of the GPx family, which showed that expression of some GPxs, such as GPx1 
and GPx3, respond quickly and are lost in response to selenium depletion, whereas 
selenium repletion causes a fast de novo synthesis of these GPxs (Bermano, Nicol et al. 
1995, Lei, Evenson et al. 1995, Wingler, Bocher et al. 1999, Fujieda, Naruse et al. 2007). 
More specifically, even a moderate Se-deficiency leads to a strong decrease in expression of 
GPx1 and GPx3, whereas GPx2 and GPx4 expression is barely affected under these 
conditions. Findings mainly obtained from mouse knockout studies indicated that GPx4 is of 
paramount importance for murine embryogenesis (Conrad 2009), whereas knockout of 
GPx1, 2 and 3 does not impact on embryonic development nor affects normal life (Conrad 
and Schweizer 2010).  
 
 
1.2 The advantage of selenothiol-based catalysis 
 
It has still remained largely unclear why some organisms utilize selenothiol- instead of thiol-
based catalysis in a number of proteins. Initial attempts to provide a molecular explanation 
for this still unclear phenomenon were made by Arnér’s laboratory using human thioredoxin 
reductase 1 (TrxR1) as a model enzyme (Gromer, Johansson et al. 2003). Mammalian 
TrxR1 was compared with the non-selenium containing homologue of Drosophila 
melanogaster (Drosophila). Thioredoxin reductases form homodimers and align in a head to 
tail fashion. Thereby, the redox centre of the N-terminal region of one monomer interacts with 
the C-terminal redox centre of the second monomer (Cheng, Sandalova et al. 2009). In 
mammals the C-terminal active site consists of a peroxidative Sec (initiates the reduction of 
the substrate by formation of an intermolecular bond) and a  resolving Cys (completes 
reduction of the substarte by a nucleophilic attack on the intermolecular bond, tunring it into a 
intramolecular bond), the Sec being the penultimate amino acid. Due to the easily oxidisable 
selenolate anion (lower pKa), selenoproteins are considered to be by two or three orders of 
magnitude more active than their Cys-containing counterparts (Lee, Bar-Noy et al. 2000). 
Yet, there is no notable difference in measurable thioredoxin reductase activity between 
human and Drosophila thioredoxin reductase 1, although the later is a Cys-containing variant 
(Gromer, Johansson et al. 2003). It appears that the pKa of the non-selenium catalytic site in 
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the Drosophila enzyme is lowered by the surrounding acidic amino acids (serines), thus 
enabling an equal activity when compared to the selenium-containing mammalian 
counterpart. As expected the substitution of Sec by Cys, in the mammalian selenoenzyme 
was shown to lead to a drastic reduction in its activity (Gromer, Johansson et al. 2003). On 
the contrary, when the amino acids surrounding the active site of the Sec/Cys variant of 
mammalian TrxR1 were mutated in a way that resembled the Drosophila homologue, the 
specific activity of mammalian TrxR1 could be increased. In fact, this Sec/Cys variant was 
equally active as the wild-type TrxR1 enzyme, when tested with the model substrate DTNB 
(Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid)) or thioredoxin itself (Gromer, 
Johansson et al. 2003). The only detectable difference was a decreased substrate spectrum 
of the Sec/Cys variant, in part due to the alterations of the surrounding amino acids, which 
led to a conformational change in the protein acceptor site (Gromer, Johansson et al. 2003). 
These studies indicated that Sec may be essential for ensuring full functionality and 
preserving broad substrate specificity at least for mammalian TrxR1.  
 
 
1.3 Selenocysteine incorporation mechanisms  
 
The amino acid Sec was discovered as a component of distinctive proteins in bacteria, 
archaea and eukarya (Low and Berry 1996, Stadtman 1996, Rother, Resch et al. 2001), 
which is encoded by an in-frame UGA codon that requires various factors in trans and cis for 
decoding.The mechanism for the insertion of Sec into the nascent polypeptide chain is 
different between bacteria and mammals. The mammalian incorporation mechanism is more 
complex than the bacterial one which can be explained by the difference in position and 
structure of the selenocystein insertion sequence (SECIS) element and the structure of the 
ribosomes. While in bacteria the SECIS element is positioned immediately downstream of 
the Sec codon, and therefore also part of the coding region, in mammals it is located in the 3’ 
UTR, and therefore can be quite far away from the actual Sec codon. Due to these intrinsic 
differences in the SECIS positioning and the different factors involved in selenoprotein 
decoding, recombinant expression of mammalian selenoproteins in bacteria is strongly 
hindered. The different mechanisms of bacterial and mammalian selenoprotein translation 
are illustrated in Figure 1 and Figure 2.  
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1.3.1 Eubacterial selenoprotein synthesis 
 
In Escherichia coli (E. coli) the biosynthesis and co-translational incorporation mechanism of 
selenocysteine into selenoproteins (Figure 1) requires the products of four genes, selA, 
encoding the selenocysteine synthetase, which catalyses the formation of Sec from Ser 
bound to tRNASec, selB, the selenocysteine-specific elongation factor, selC, the 
selenocysteine-specific tRNASec and selD, the selenophosphate synthetase.  
SelD catalyses the selenium donor, seleniumphosphate, from ATP and reduced selenium 
(Sturchler-Pierrat, Hubert et al. 1995). The elongation factor SelB has a N-terminal part that 
is structurally homologous to the three domains of elongation factor Tu (EF-Tu, which is 
involved in the incorporation of the other 20 amino acids) (Hilgenfeld, Bock et al. 1996, 
Tormay, Sawers et al. 1996), and a C-terminal extension involved in the binding of the 
SECIS element (Kromayer, Wilting et al. 1996). In prokaryotic mRNAs, the SECIS element is 
located just downstream of the UGA codon as part of the coding region of the selenoprotein, 
where it may also act as an inhibitor of translational read-through (Engelberg-Kulka, Liu et al. 
2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mechanism of UGA decoding and Sec incorporation in eubacteria. SelB (shown in yellow) is a 
SECIS binding protein and a specialized translation elongation factor, the nascent polypeptide chain is shown in 
blue and Sec in red.   
 
Genetic and biochemical studies suggested that SelB catalyses the same functions as EF-
Tu. In its GTP-bound form, EF-Tu binds the aminoacylated tRNA forming the ternary 
complex and transfers the activated tRNA to the ribosome. In the initial selection step, 
dissimilar ternary complexes are dissociated from the ribosome. When equivalent ternary 
complexes form proper anticodon-codon interactions, the GTPase activity of EF-Tu is 
increased, which induces a strong conformational change (Berchtold, Reshetnikova et al. 
1993). This leads to (i) a reduction in the affinity for the bound tRNA, (ii) to the release of the 
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tRNA to the ribosomal A site, and (iii) the dissociation of EF-Tu-GDP from the ribosome. 
SelB can only recognize the tRNASec when it is loaded with selenocysteine (Sec-tRNASec) 
and not the precursor form loaded with serine (Ser-tRNASec) (Forster, Davies et al. 1990), 
unlike EF-Tu that is able to recognize 40 different tRNA species loaded with one of the 20 
classical amino acids. Most importantly, SelB does not form a ternary, but rather a 
quaternary complex with selenocysteyl-tRNASec, GTP and the SECIS element, which 
eventually leads to correct Sec insertion (Heider, Baron et al. 1992, Baron, Westhof et al. 
1993, Ringquist, Schneider et al. 1994). The pre-formation of the quaternary complex is 
essential for the decoding process (Tormay, Sawers et al. 1996). A successful interaction 
with the ribosome leads to the stimulation of GTP hydrolysis (Huttenhofer and Bock 1998), 
and it can occur only when the quaternary complex is formed.  
 
 
1.3.2 Mammalian Sec incorporation mechanism  
 
Selenoprotein translation relies on the incorporation of Sec at the encoding UGA codon 
through a highly complex mechanism that requires several different cis and trans acting 
factors (Figure 2) (Allmang, Wurth et al. 2009). Also, the loading of the Sec-specific tRNA 
with Sec differs significantly from bacteria (Donovan and Copeland 2010). In brief, inorganic 
selenide is activated to selenophosphate by selenophosphate synthetase. Selenophosphate 
is processed by selenocysteyl-tRNA-synthetase which catalyses the substitution of Ser to 
Sec in Ser-tRNA[Ser]Sec, yielding Sec-tRNA[Ser]Sec. In contrast to the bacterial SECIS, the 
mammalian SECIS element is positioned in the 3´-untranslated region (UTR) of the mRNA. 
Apart from this cis acting element trans acting elements are also needed, e.g. the SECIS 
binding protein 2 (SBP2), the ribosomal protein L30 (rpL30), and the EF-Tu-like elongation 
factor EFSec (Copeland 2003, Caban and Copeland 2006) (Figure 2).  
The distance of the UGA codon and the SECIS element can be as far as 4000 bp in 
eukaryotes in contrast to eubacterial positioning of the SECIS element (Buettner, Harney et 
al. 1998). Eukaryotic SECIS elements are composed of two helices, an internal and apical 
loop, and a conserved non-Watson-Crick interacting nucleotide quartet, located at the base 
of helix 2 (Copeland, Fletcher et al. 2000, Low, Grundner-Culemann et al. 2000). Some large 
apical loops contain an additional mini-stem that presumably stabilizes the SECIS element. 
SBP2 is recruited in eukaryotic cells by the SECIS element to form a stable SECIS-SBP2 
complex (Copeland, Fletcher et al. 2000, Low, Grundner-Culemann et al. 2000). SBP2 binds 
the elongation factor EFsec, which in turn recruits Sec-loaded tRNA[Ser]Sec (Fagegaltier, 
Hubert et al. 2000, Tujebajeva, Copeland et al. 2000). This complex translocates to the 
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ribosome, where tRNA[Ser]Sec is released to the ribosomal A-site by GTP hydrolysis (Chavatte, 
Brown et al. 2005). The eukaryotic ribosomal protein L30 has been implicated in Sec 
incorporation. L30 is considered to replace SBP2 upon binding of the complex to the 
ribosome, triggering the release of tRNA[Ser]Sec. Eventually, the polypeptide chain at the P-site 
is transferred to the tRNA[Ser]Sec, forming a peptide bond with Sec. The elongation factor 
EFsec is specific for Sec incorporation and differs from EF-Tu, which is involved in the 
aminoacyl-tRNA delivery of the other 20 amino acids (Chavatte, Brown et al. 2005). 
Recently, SEC43a has been implicated in selenoprotein biosynthesis. SEC43a forms a 
complex with tRNA[Ser]Sec. Targeted knockdown of this factors reduced overall selenoprotein 
biosynthesis (Xu, Perez et al. 2005), but detailed characterization of this factor requires 
further studies. SBP2 along with EFsec constitute the functional equivalent of a single 
elongation factor in prokaryotic selenoprotein synthesis, designated SelB (Forchhammer, 
Leinfelder et al. 1989).  
Figure 2: Mechanism of mammalian UGA decoding and Sec incorporation. Depicted is the shuttling of the 
SPS1/SECp43/EFSec/Sec-tRNA[Ser]Sec complex (light green/ pink/ blue/ black) into the nucleus and association 
with SBP2 (yellow) and the SECIS element. Cytoplasmic translocation of the SECIS-bound complex is shown on 
the left, the nascent polypeptide chain in dark blue and Sec in red.  
 
Naturally occurring mutations in the human SBP2 were shown to result in a complex 
phenotype (Schoenmakers, Agostini et al. 2010). Azoospermia, combined with a failure of 
spermatogenesis in later stages, is probably due to a lack or decreased expression of certain 
selenoproteins in testis. Also, an axial muscular dystrophy could be found, showing features 
comparable to myopathies caused by mutations in selenoprotein N (SEPN1) (Arbogast, 
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Beuvin et al. 2009, Papp, Holmgren et al. 2010). Due to deficiencies in antioxidant 
selenoenzymes, cellular reactive oxygen species (ROS) were increased in peripheral blood 
cells in patients carrying SBP2 mutations. Additionally telomere shortening could be detected 
as part of the phenotype. Strangely enough, increased ROS levels were associated with 
enhanced systemic and cellular insulin sensitivity (Schoenmakers, Agostini et al. 2010). 
Cellular depletion of SBP2 leads to oxidative stress and induction of caspase-3 and 
cytochrome c-dependent apoptosis (Papp, Lu et al. 2010). SBP-2 deletion also caused 
higher levels of ROS, and an increase in 8-oxo-7,8-dihydroguanine (8-oxo-dG) DNA lesions, 
stress granule formation, lipid peroxidation and cell death. Interestingly, antioxidants like N-
acetylcysteine, glutathione, and alpha-tocopherol only slightly reduced ROS levels and were 
unable to rescue SBP-2 knockdown cells fully from apoptosis. This indicates that apoptosis 
might be mediated by various selenoproteins simultaneously, indicating that SBP2 is 
required for protection against ROS-induced cellular damage and cell survival (Papp, Lu et 
al. 2010).  
It has been reported that read-through of the UGA in mammalian selenoprotein mRNAs is 
only ~2 % of that of a cysteine codon in the same position (Berry, Maia et al. 1992, Kollmus, 
Flohe et al. 1996, Suppmann, Persson et al. 1999). Yet it is still unknown whether this is due 
to chain termination at the UGA competing with Sec insertion or to kinetic impairment due to 
the highly complex insertion mechanism in eukaryotes.  
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1.4 Glutathione peroxidase 4 (GPx4)  
 
1.4.1 Genetic and molecular structure  
 
GPx4 (also known as phospholipid hydroperoxide glutathione peroxidase, PHGPx) was first 
purified from pig liver in 1982 by Ursini and colleagues and characterized as a protein 
efficiently protecting liposomes and biomembranes from peroxidative degradation in the 
presence of glutathione (GSH) (Ursini, Maiorino et al. 1982). GPx4 shares the least 
sequence homology with the other GPxs and significantly differs from its family members in 
terms of its monomeric structure, low substrate specificity, and its necessity for mouse 
development (Imai, Hirao et al. 2003, Yant, Ran et al. 2003, Conrad, Schneider et al. 2007, 
Seiler, Schneider et al. 2008). Three different forms of mammalian GPx4 exist, which show 
distinctive subcellular localization and tissue-specific expression. Each variant is transcribed 
from a distinct start codon within the same gene (Figure 3). Alternative transcription initiation 
leads to the expression of either the short (cytosolic) form (GPx4) (170 aa/20 kDa), the 
mitochondrial (long) form (mGPx4) (197 aa/23 kDa), with an N-terminal mitochondrial leader 
sequence, or the 34 kDa nuclear form of GPx4 (253 aa/nGPx4), previously referred to as 
sperm nuclei-specific GPx (snGPx) (Pfeifer, Conrad et al. 2001).  
 
Figure 3: Exon-intron structure of mammalian GPx4. GPx4 consists of 7 “classical” exons (E) and one 
alternative exon (EA), located between exon 1 and 2. The mitochondrial (197 aa) and cytosolic (170 aa) start 
codons are encoded by E1. The sperm nuclei-specific form of GPx4 (253 aa) is transcribed from the EA. The EA 
encodes a nuclear targeting signal and clusters rich in basic amino acids, most probably required for binding of 
nuclear GPx4 to DNA. The Sec codon (yellow asterisk) is encoded for by exon 3. The SECIS element (red 
asterisk) is located on E7. For the short and long forms of GPx4 EA is spared by splicing. 
 
The alternative exon (EA), localised between the classical exons 1 and 2, encodes a nuclear 
targeting sequence as well as clusters rich in arginine and lysine, which are also found in 
protamines. Protamines are small, arginine-rich, nuclear proteins that replace histones in 
GPx4 
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spermatids. They are essential for sperm head condensation and DNA stabilization (Balhorn 
2007). The cytosolic form of GPx4 is ubiquitously expressed, whereas the mitochondrial and 
the nuclear form are mainly expressed in testis (Pushpa-Rekha, Burdsall et al. 1995, Pfeifer, 
Conrad et al. 2001, Schneider, Vogt Weisenhorn et al. 2006). The primary protein structure 
of the short and long form of GPx4 is identical except for the Mls at the N-terminus (Figure 
4). The bulk amount of the long form is exclusively expressed in male testis (Ursini, Heim et 
al. 1999, Maiorino, Roveri et al. 2005). 
 
Figure 4: Primary amino acid sequence of mammalian GPx4. Shown is the amino acid sequence of the 
primary strcture of the short form of GPx4 (black). The long form consists of the same amino acid sequence with 
an additional 27 amino acid Mls sequence (red). Mutated aa are shown in colour green (Mls) and blue (common 
sequence) including their position within the respective polypeptide chain. 
 
Although the overall amino acid sequence homology of GPx4 is less than 40 % compared 
with other Sec-containing GPxs, they do share conserved motifs, particularly the catalytic 
tetrad, made up of Sec, Gln, Trp and Asn (Figure 5).  
 
Figure 5: Crystral structure of human GPx4. The 3D model of GPx4 was rotated and labelled to show the 
catalytic tetrad of human GPx4 (U46, Q81, W136 and N137), which is labelled in red. Structural features are 
encoded as follows; α-helices in red, β-sheets in light green, flexible linker regions in violet and other aa in grey. 
GPx4 
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This conserved tetrad has been shown to form a catalytic centre in which the selenol group 
of Sec is stabilized and activated by hydrogen bonds, provided by the Gln and Trp residues 
(Maiorino, Aumann et al. 1995). An initial mutational and biochemical approach by Maiorino 
et al. revealed that the conversion of Sec to Cys in pig GPx4 causes a decrease of GPx4 
activity by about three orders of magnitude in the recombinant protein (Maiorino, Aumann et 
al. 1995). Furthermore biochemical in vitro experiments suggested that a change in pH, due 
to the substitution of amino acids in the catalytic tetrad might have a negative effect upon 
GPx4 function (Tosatto, Bosello et al. 2008).  
 
 
1.4.2 Catalytic mechanism of GPx4 
 
The catalytic mechanism appears to be similar among all GPxs. Except for GPx4 the 
intermediate steps have not been formally proven e.g. by the use of mass spectrometry.  
GPx4 catalysis involves redox shuttling of the Sec residue within the active site (Figure 6). 
The dissociated selenol (-Se-) from Sec is oxidized by a hydroperoxide to yield selenenic 
acid (-SeOH) and water. The selenenic acid reacts with a free thiol (-SH), typically GSH, to 
form an intermediate selenenyldisulfide, which in turn is resolved by a second GSH molecule 
(Figure 6 A).  
 
Figure 6: The catalytic cycle of GPx4. The selenol (GPx4-Se-) is first oxidized by a hydroperoxide to selenenic 
acid (GPx4-SeOH), following reduction to an intermediate selenodisulfide with GSH (A) or other thiol containing 
substrate (B). GPx4 is reconstituted into its ground state by a second reducing equivalent, yielding an oxidized 
GSH dimer (GSSG) (A) or another thiol containing substrate (B) (adopted from (Conrad 2009)) R, R1 and R2 mark 
protein moieties. 
 
In contrast to other GPxs, GPx4 does not only use GSH as a reducing factor. It has been 
shown for instance in mature spermatozoa, that GPx4 reacts with thiols in proteins, in 
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particular when GSH is limited. In mature spermatozoa nGPx4 acts as a protein thiol 
peroxidase by introducing disulfide bridges into protamines, and thus contributes to the 
structural stability of sperm chromatin (Conrad, Moreno et al. 2005) (Figure 6 B).  
In addition to H2O2 and lipid hydroperoxides, both common substrates of glutathione 
peroxidases, GPx4 efficiently reduces phospholipid hydroperoxides within biological 
membranes and in lipoprotein particles (Ursini, Maiorino et al. 1982). For this reason, GPx4 
has been implicated in the protection of cellular membranes against oxidative damage. Two 
structural features may explain the broad substrate specificity of GPx4. Firstly, GPx4 acts as 
a monomer and the active site selenol is displayed on the hydrophobic surface of the 
enzyme. Secondly, arginine residues that direct GSH to the active site are present in GPx1, 
GPx2 and GPx3, but are missing in GPx4. Instead, two lysine residues (Lys48, Lys125), 
which are less specific for GSH, guide the sulphur atom of various thiol-containing molecules 
to the active site of GPx4 (Ursini, Maiorino et al. 1997, Ursini, Heim et al. 1999, Roveri, Ursini 
et al. 2001, Mauri, Benazzi et al. 2003). 
 
 
1.4.3 Cellular functions of GPx4 
 
1.4.3.1 The cytosolic form of GPx4 
 
Due to its peroxidative function, GPx4 has been frequently linked with apoptosis regulation. 
For instance, forced expression of GPx4 protects from many apoptotic triggers like pro-
oxidants, DNA damaging agents, glucose depletion and irradiation (reviewed in (Conrad, 
Schneider et al. 2007)). GPx4 also protects Burkitt’s lymphoma cells from oxidative stress-
induced cell death imposed by low cell density (Brielmeier, Bechet et al. 2001). 
Besides its “antiapoptotic” function, GPx4 regulates the arachidonic acid metabolising 
enzymes lipoxygenases (LOX) and cyclooxygenases (COX) like other GPxs. COX converts 
arachidonic acid into prostaglandin (PG)G2 and later to PGH2, the precursor of various 
prostanoids (Funk 2001). LOX oxygenates arachidonic acid at different positions and the 
resulting hydroperoxyeicosatetraenoic acids (HPETE) are subsequently either reduced to 
hydroxyeicosatetraenoic acid (HETE) or transformed into leukotrienes, hepoxilins or lipoxins 
(Funk and Cyrus 2001). As LOX and COX require a certain cellular peroxide level for initial 
activation and full activity (Ivanov, Saam et al. 2005), GPx4 must be considered as one of the 
main regulators of both types of enzymes. This hypothesis is supported by the fact that GPx4 
knock-down leads to up-regulation of 12-LOX and COX 1 enzym activities in a human 
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carcinoma cell line (Chen, Huang et al. 2003), while GPx4 overexpression impairs 
arachidonic acid metabolism and leukotriene secretion. Furthermore, GPx4 controls also 5-, 
12-, and 15-LOX activities (reviewed in  (Conrad, Schneider et al. 2007)). 
Interestingly, it was shown that only the short form of GPx4 is essential for survival of mice 
(Liang, Yoo et al. 2009). In the same study it was also shown that it can localise to 
mitochonria, despite the lack of a mitochondrial signalling peptide at its N-terminus. The 
presence of the short form of GPx4 in mitochondria was identical with the one observed in 
wild-type mice but male mice expressing only the short form of GPx4 showed sperm 
malformations and were infertile (Schneider, Forster et al. 2009). It therefore seems that the 
short form of GPx4 is responsible for proper embryonic development and function of adult 
tissues, whereas the long form of GPx4 is only important for male fertility (Schneider, Forster 
et al. 2009).  
 
 
1.4.3.2 The long (mitochondrial) form of GPx4 (mGPx4) 
 
As described above, a peculiarity of GPx4 is its less restricted specificity for its reducing 
agent GSH (Ursini, Maiorino et al. 1997). Ursini and colleagues were the first to provide in 
vivo proof that GPx4 is able to inactivate itself during sperm maturation (Ursini, Heim et al. 
1999). It was discovered that GPx4 acts as the major structural protein of the mitochondrial 
capsule of spermatozoa where it is cross-linked with other capsular proteins. Due to this 
cross-linking it appears to be present in an inactive form as it lacks GPx4 enzyme activity. 
Later it was also shown, that GPx4 is cross-linked with other capsular proteins via 
(selenenyl)disulfide bridges (Ursini, Heim et al. 1999, Maiorino, Roveri et al. 2005). As 
maturing sperm cells are practically devoid of GSH, the mechanism of inactivation is thought 
to be related to GSH depletion (Shalgi, Seligman et al. 1989). 
Knockout studies of mice lacking exclusively the mitochondrial form revealed that mGPx4 
null mice are fully viable (Schneider, Forster et al. 2009). GPx4 expression levels were 
shown to be strongly decreased in testis while other organs did not display any differences, 
demonstrating for the first time that mGPx4 is the prevailing form in testis. As male mGPx4-/- 
mice are infertile it became clear that mGPx4 plays an essential role in spermatogenesis 
(Schneider, Forster et al. 2009). Ultrastructural analysis revealed severe sperm abnormalities 
in the midpiece of mature spermatozoa, which are typical features of sperm derived from 
selenium-deprived rodents (Wallace E. 1983, Watanabe and Endo 1991). Apparently, 
mGPx4 is required as an essential structural component of mitochondrial capsules in sperm, 
but it may also be involved in the cross-linking of capsular proteins. These studies firmly 
established that mGPx4 confers the vital role of selenium in male fertility (Schneider, Forster 
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et al. 2009) after first observations that rodents kept on a Se low diet develop male infertility 
(Gunn, Gould et al. 1967).  
 
 
1.4.3.3 The nuclear form of GPx4 (nGPx4) 
 
In 2001, a collaborative study between Behne’s and Conrad’s groups reported on a 
selenoprotein in rats, which was exclusively expressed in the nuclei of late spermatids. Its 
appearance coincides with the reorganization of DNA, which leads to a highly condensed 
chromatin stabilized by cross-linked protamine thiols (Pfeifer, Conrad et al. 2001). This 
selenoprotein was discovered as a novel form of GPx4, called sperm-nuclei specific GPx4 
(previously referred to as snGPx4, now nGPx4). Subsequent studies revealed that nGPx4 is 
expressed from its own promoter and exclusively expressed in testis (Moreno, Laux et al. 
2003). Knockout studies targeting exclusively the nuclear form provided first in vivo proof that 
GPx4 harbors protein thiol peroxidase activity in vivo (Moreno, Laux et al. 2003). Yet nGPx4 
knockout mice are fully viable and only show a delayed chromatin condensation during 
spermatogenesis. The nuclear form of GPx4 has a long N-terminal extension (~ 15 kDa) 
encoding for a nuclear localization signal and clusters rich in arginine and lysine residues 
(Pfeifer, Conrad et al. 2001). The latter are most likely required for binding of nGPx4 to DNA 
in order to introduce disulfide bridges into protamines to ensure a tightly packed and 
protected male genome of sperm cells (Conrad, Moreno et al. 2005). Due to the specific role 
of nGPx4 in sperm chromatin compaction, it was not included in experiments performed in 
this work. 
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1.5 Objectives 
 
While the impact of the overall cellular redox balance on cell decisions has been recognized 
in recent years, systems that sense and transduce changes in redox balance and thus 
control distinctive cellular pathways are still poorly understood. The main reasons are (i) the 
high complexity and partial redundancy of cellular redox systems in particular the glutathione 
and thioredoxin dependent systems, (ii) the very transient nature of redox-regulated 
processes and thus inherent technical limitations, and (iii) limitations of suitable knockout 
models allowing to address the molecular mechanisms of cellular redox control. In addition, 
interacting partners as well as novel substrates of redox enzymes are largely unknown.  
The selenoenzyme GPx4 is emerging as an important redox controlling enzyme in mammals. 
This was confirmed by targeted disruption of GPx4 in mice, which is associated with early 
embryonic lethality. While some aspects of GPx4, in particular its antioxidant function and its 
significance in male spermatogenesis, have been analysed to some extent, experimental 
systems to study its suspected role as a mammalian redox sensor have been lacking so far. 
The role of GPx4 in the cellular redox network is only beginning to be recognized. Therefore, 
the specific aims of this study were: 
  
• To elucidate the functional relevance of the catalytically active Sec in the cell 
death preventing effect of GPx4 based on previous studies performed in our 
laboratory 
• To investigate the significance of the remaining amino acids of the catalytic tetrad 
of GPx4 in cells 
• To study the functional role of the remaining Cys, which would also allow to 
identify a new Cys as a possible resolving Cys in the catalytic cycle 
 
In conclusion, these studies would provide novel insights concerning the structure-function 
relationship of distinct Cys (Sec) residues of one of the most central redox-regulating 
enzymes in mammals, glutathione peroxidase 4, and address a possible advantage of 
selenothiol- versus thiol-based catalysis in view of a rescuing effect in vitro.  
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2 Materials 
 
2.1 Antibodies  
 
Antibody (source)___________Company_______________________Catalog-No. 
 
α -Actin  (rabbit)    Santa Cruz Biotechnology, Heidelberg, Germany  sc-58679 
α-FLAG (mouse)    Sigma-Aldrich GmbH, Taufkirchen, Germany  F2555 
α-HA High Affinity, clone 3F10 (rat)  Roche Diagnostics, Mannheim, Germany   11 867 423 001 
α-Mouse-HRP conjugate (goat)   Promega GmbH, Mannheim, Germany   W4021 
α-GPx4 mGPx4 1B4 (rat)    Elisabeth Kremmer, HMGU, Munich, Germany 
α-Rabbit-Cy5 conjugate (goat)   Invitrogen, Karlsruhe, Germany   A21244 
α-rabbit-HRP conjugate (goat)  Santa Cruz Biotechnology, Heidelberg, Germany  sc-2768 
α-Rat-HRP conjugate (goat)   Dianova GmbH, Hamburg, Germany   112-035-062 
α-Rat-Cy3 conjugate (mouse)   Jackson Immunoresearch Europe Ltd., UK   212-165-168 
α-alpha-Tubulin (mouse)    Sigma-Aldrich GmbH, Taufkirchen, Germany  T6199 
Mitotracker Red CMXRos   Invitrogen, Karlsruhe, Germany   M7512 
 
Table 2: Antibodies and dilutions used in this thesis. 
Antibody Used in Dilution 
α -Actin  (rabbit)Immunoblot 1:1000 
α-FLAG (mouse) Immunoblot 
Immunofluorescence 
1:1000 
1:200 
α-HA High Affinity, clone 3F10 (rat) 
supernatent 
Immunoblot 1:5 
α-Mouse-HRP conjugate (goat) Immunoblot 1:1000 
α-GPx4 mGPx4 1B4 (rat) 
supernatant 
Immunoblot 
Immunofluorescence 
1:5 
1:1 
α-Rabbit-Cy5 conjugate (goat) Immunofluorescence 1:100 
α-rabbit-HRP conjugate (goat) Immunoblot 1:1000 
α-Rat-HRP conjugate (goat) Immunoblot 1:1000 
α-Rat-Cy3 conjugate (mouse) Immunofluorescence 1:200 
α-alpha-Tubulin (mouse) Immunoblot 1:1000 
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2.2 Bacteria 
 
Strain________________Company______________________________________ 
 
DH5α cells    Invitrogen, Karlsruhe, Germany 
 
 
2.3 Cell lines 
 
HEK293 T cells were used as packaging cell line for the production of lentiviral particles, based on the 
third generation lentiviral vector p442-PL1. (Kafri, van Praag et al. 1999) 
 
Immortalized MEFs were derived from primary MEFs, which were isolated from embryos carrying 
either one or two loxP-flanked GPx4 alleles, yielding PFa43(flox/wt), PFa1(flox/flox), PFa24(flox/flox), and 
PFa37(flox/flox) cells, respectively (Seiler, Schneider et al. 2008). MEFs were transfected with pCAG-
3SIP-MCM, yielding cell line PFa1(flox/flox)-MCM, PFa24(flox/flox)-MCM, PFa37(flox/flox)-MCM, and 
PFa43(flox/wt)-MCM, respectively(Seiler, Schneider et al. 2008). The cell-lines PFa1(flox/flox)-MCM and 
PFa43(flox/wt)-MCM were used for the studies described in this work. 
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2.4 Chemicals 
 
Chemicals_________________Company_______________________ Catalog-No. 
 
Acrylamide     Bio-Rad, Munich, Germany    161-0158 
Agarose, electrophoresis grade   Invitrogen, Karlsruhe, Germany    15510-027 
Agarose, low melting point   Fermentas GmbH, St. Leon-Rot, Germany   R0801 
Ammonium persulfate    Sigma-Aldrich GmbH, Taufkirchen, Germany  A3678 
Ampicillin     Sigma-Aldrich GmbH, Taufkirchen, Germany  A9518 
α-Tocopherol (Toc)    Sigma-Aldrich GmbH, Taufkirchen, Germany  T3251 
β-Mercaptoethanol (2-ME)   Roth Carl GmbH & Co., Karlsruhe, Germany  4227.1 
Bovine Albumin     MP Biomedicals, Eschwege, Germany   840043 
Bromophenol Blue Sodium Salt   Merck KGaA, Darmstadt, Germany   111746 
Buthionine Sulfoximine (BSO)   Sigma-Aldrich GmbH, Taufkirchen, Germany  B2640 
4´,6-diamidino-2-phenylindole (DAPI)  Invitrogen, Karlsruhe, Germany    D1306 
dNTP Mix     Fermentas GmbH, St. Leon-Rot, Germany   R0241 
DMSO (Dimethylsulfoxide)   Sigma-Aldrich GmbH, Taufkirchen, Germany  D2650 
DTT (Dithiothreitol)    Sigma-Aldrich GmbH, Taufkirchen, Germany  D8161 
ECL      GE Healthcare, Freiburg, Germany   RPN2106 
EDTA      Sigma-Aldrich GmbH, Taufkirchen, Germany  E9884 
EGTA     Sigma-Aldrich GmbH, Taufkirchen, Germany O3777 
Ethanol p.a.     Merck, Darmstadt, Germany    1.00983.2500 
Ethidiumbromide    Merck, Darmstadt, Germany    70257083 
Foetal Bovine Serum    PAA, Pasching, Austria     A15-043 
Glutathione (GSH)    Sigma-Aldrich GmbH, Taufkirchen, Germany  G6013 
Glycine      MP Biomedicals, Eschwege, Germany   808831 
Gelatin from porcine skin    Sigma-Aldrich GmbH, Taufkirchen, Germany  G2500 
Hydroperoxide     Sigma-Aldrich GmbH, Taufkirchen, Germany  H1009 
4-Hydroxytamoxifen (Tam)   Sigma-Aldrich GmbH, Taufkirchen, Germany  H7904 
Isopropyl-β-d-thiogalactopyranoside (IPTG) Sigma-Aldrich GmbH, Taufkirchen, Germany I6758 
Iodoacetamide     Sigma-Aldrich GmbH, Taufkirchen, Germany  I6125 
Isopropanol p.a.     Merck, Darmstadt, Germany    1.09634.2511 
L-Glutamine     Invitrogen, Karlsruhe, Germany    25030 
Mounting medium    Dako Cytomation, Hamburg, Germany   S3023 
N-Acetyl-L-Cysteine    Sigma-Aldrich GmbH, Taufkirchen, Germany  A9165 
Oligonucleotides     Metabion GmbH, Martinsried, Germany 
Pareformaldehyde (PFA)    Roth Carl GmbH & Co., Karlsruhe, Germany  0335.3 
Penicillin-Streptomycin    Invitrogen, Karlsruhe, Germany    15140-122 
Phenol     Sigma-Aldrich GmbH, Taufkirchen, Germany P1037 
Phenol:Chloroform:Isoamylalcohol  MP Biomedicals, Eschwege, Germany   802520 
Propidium Iodide (PI)    Sigma-Aldrich GmbH, Taufkirchen, Germany  P4170 
Protease Inhibitor Cocktail   Tablets Roche Diagnostics, Mannheim, Germany  1 697 498 
Puromycin     Sigma-Aldrich GmbH, Taufkirchen, Germany  P7255 
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Chemicals_________________Company_______________________ Catalog-No. 
 
Select Agar     Invitrogen, Karlsruhe, Germany    30391-023 
Skim Milk Powder    Fluka Chemie GmbH, Buchs, Switzerland   70166 
Sodium Chloride     MP Biomedicals, Eschwege, Germany   194848 
Sodium Deoxocholate    Sigma-Aldrich GmbH, Taufkirchen, Germany  D6750 
Sodium Dodecyl Sulfate (SDS)   Fluka Chemie GmbH, Buchs, Switzerland   71729 
Sodium Hydroxide   Roth Carl GmbH & Co., Karlsruhe, Germany  UN1823 
Sodium Pyrophosphate Tetrabasic 
Decahydrate     Sigma-Aldrich GmbH, Taufkirchen, Germany  S6422 
TEMED      Fluka Chemie GmbH, Buchs, Switzerland   87689 
Tris-Base     Merck, Darmstadt, Germany    1.08382 
Triton X-100     GE Healthcare, Freiburg, Germany   17-1315-01 
Trypan Blue (0.4%)    Sigma-Aldrich GmbH, Taufkirchen, Germany  T8154 
Trypsin-EDTA     Invitrogen, Karlsruhe, Germany    25300 
Tween 20     Sigma-Aldrich GmbH, Taufkirchen, Germany  P5927 
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2.5 Cloning 
 
Sequence of GPx4 cDNA: (Mls is shown in red and the codons mutated in this work are shown in 
bold) 
ATGAGCTGGGGCCGTCTGAGCCGCTTACTTAAGCCAGCACTGCTGTGCGGGGCTCTGGCTGCGCCTGGTCT
GGCAGGCACCATGTGTGCATCCCGCGATGATTGGCGCTGTGCGCGCTCCATGCACGAATTCTCAGCCAAGG
ACATCGACGGGCACATGGTCTGCCTGGATAAGTACAGGGGTTTCGTGTGCATCGTCACCAACGTGGCCTCG
CAATGAGGCAAAACTGACGTAAACTACACTCAGCTAGTCGATCTGCATGCCCGATATGCTGAGTGTGGTTTA
CGAATCCTGGCCTTCCCCTGCAACCAGTTTGGGAGGCAGGAGCCAGGAAGTAATCAAGAAATCAAGGAGTT
TGCAGCCGGCTACAACGTCAAGTTTGACATGTACAGCAAGATCTGTGTAAATGGGGACGATGCCCACCCACT
GTGGAAATGGATGAAAGTCCAGCCCAAGGGCAGGGGCATGCTGGGAAATGCCATCAAATGGAACTTTACCA
AGTTTCTCATTGATAAGAACGGCTGCGTGGTGAAGCGCTATGGTCCCATGGAGGAGCCCCAGGTGATAGAG
AAGGACCTGCCGTGCTATCTCTAG 
 
Plasmids: 
Table 3: Different plasmids used in this thesis. 
Name Source Type Modification 
pDrive-FSH-
GPx4 
 
(Seiler, 
Schneider et 
al. 2008) 
Intermediate None 
pDrive-FSH-
GPx4-NheI-kill 
This work Intermediate 
deletion of the NheI site upstream of GPx4 using 
the NheI-kill primer pair 
pDrive-FSH-
GPx4-U46C-
NheI-kill 
This work Intermediate 
Mutation of Sec to Cys using the GPx4U46C 
primer pair 
pDrive-FSH-
GPx4-C2S-NheI-
kill 
This work Intermediate 
Mutation of Cys at position 2 to Ser using the 
GPx4C2S primer pair 
pDrive-FSH-
GPx4-C10S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 10 to Ser using the 
GPx4C10S primer pair 
pDrive-FSH-
GPx4-C37S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 37 to Ser using the 
GPx4C37S primer pair 
pDrive-FSH-
GPx4-C66S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 66 to Ser using the 
GPx4C66S primer pair 
pDrive-FSH-
GPx4-C75S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 75 to Ser using the 
GPx4C75S primer pair 
pDrive-FSH-
GPx4-C107S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 107 to Ser using the 
GPx4C107S primer pair 
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Name Source Type Modification 
pDrive-FSH-
GPx4-C148S-
NheI-kill 
This work Intermediate 
Mutation of Cys at position 148 to Ser using the 
GPx4C148S primer pair 
pDrive-FSH-
GPx4-C168S-
NheI-kill 
 
This work Intermediate 
Mutation of Cys at position 168 to Ser using the 
GPx4C168S primer pair 
pDrive-FSH-
GPx4-Q81A-
NheI-kill 
This work Intermediate 
Mutation of Gln at position 81 to Ala using the 
GPx4Q81A primer pair 
pDrive-FSH-
GPx4-Q81E-
NheI-kill 
This work Intermediate 
Mutation of Gln at position 81 to Glu using the 
GPx4Q81E primer pair 
pDrive-FSH-
GPx4-W136D-
NheI-kill 
This work Intermediate 
Mutation of Trp at position 136 to Asp using the 
GPx4C2S primer pair 
pDrive-FSH-
GPx4-N137A-
NheI-kill 
This work Intermediate 
Mutation of Asn at position 137 to Ala using the 
GPx4C2S primer pair 
pDrive-FSH-
GPx4-N137D-
NheI-kill 
This work Intermediate 
Mutation of Asn at position 137 to Asp using the 
GPx4C2S primer pair 
pDrive-Mls-FSH-
GPx4-NheI-kill 
This work Intermediate 
Mls sequence was added to the FSH-GPx4 via 
overlapping PCR 
pDrive-Mls-FSH-
GPx4-U46C-
NheI-kill 
This work Intermediate 
Mls sequence was added to the FSH-GPx4-
U46C via overlapping PCR 
pDrive-FSH-
GPx4-NheI-kill-
delta-SECIS 
This Work Intermediate 
Removal of the SECIS element by NheI 
digestion of pDrive-FSH-GPx4-NheI-kill 
 
pDrive-FSH-
GPx4-NheI-kill-
U46C-delta-
SECIS 
This work Intermediate 
Removal of the SECIS element by NheI 
digestion of pDrive-FSH-GPx4-U46C-NheI-kill 
FSH-GPx4-
allCys/Ser 
Geneart Intermediate All Cys in GPx4 mutated to Ser 
pDrive-FSH-
GPx4-allCys/Ser 
This work Intermediate 
Transfer of the GPx4 containing fragment (954 
Bp) via BamHI/XbaI into the same sites of pDrive 
pDrive-FSH-
GPx4-
allCys/Ser-U46C 
This work Intermediate 
Transfer of the GPx4 containing fragment (954 
Bp) via BamHI/XbaI into the same sites of pDrive 
442-PL1 Tim Schröder Expression pRRL.PPT.SF.IRES-VENUSnucmem  
391 Tim Schröder Expression K73 pEcoEnv-IRES-puro  
392 Tim Schröder Expression pRSV_Rev  
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Name Source Type Modification 
393 Tim Schröder Expression pMDLg_pRRE  
442-PL1-FSH-
GPx4 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-U46C 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
 
442-PL1-FSH-
GPx4-C2S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C10S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C37S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C66S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C75S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C107S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C148S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-C168S 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-Q81A 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-Q81E 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-W136D 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-N137A 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-N137D 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-allCys/Ser 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-FSH-
GPx4-
allCys/Ser-U46C 
This work Expression 
Transfer of the GPx4 containing fragment (954 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-Mls-
FSH-GPx4 
This work Expression 
Transfer of the GPx4 containing fragment (995 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-Mls- 
FSH-GPx4-U46C 
This work Expression 
Transfer of the GPx4 containing fragment (995 
Bp) from pDrive into 442-PL1 via BamHI/XbaI 
442-PL1-
MlsC16S-FSH-
GPx4 
This work Expression 
Mutation of Cys to Ser at position 16 in the Mls 
using the MlsC16S-GPx4 primer pair 
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Primer: 
Tabel 4: Primers and primer-pairs used in this thesis. 
 Name  Sequence  Purpose 
 GPx4U46C 
5’-GTGGCCTCGCAATGCGGCAAAACTGACGTAAAC-3’ 
5’-TTTACGTCAGTTTTGCCGCATTGCGAGGCCACG-3’ 
Substitution of Sec with 
 Cys at position 46 
 GPx4U46S 
5’-GTGGCCTCGCAAAGCGGCAAAACTGACGTAAAC-3’ 
5’-TTTACGTCAGTTTTGCCGCTTTGCGAGGCCACG-3’ 
Substitution of Sec with 
 Ser at position 46 
 GPx4C2S 
5’-GATTACGCTTCTGCATCCCGCGATGATT-3’ 
5’-AATCATCGCGGGATGCAGAAGCGTAATC-3’ 
Substitution of Cys with 
 Ser at position 2 
 GPx4C10S 
5’-GATGATTGGCGCTCTGCGCGCTCCATGC-3’ 
5’-GCATGGAGCGCGCAGAGCGCCAATCATC-3’ 
Substitution of Cys with 
 Ser at position 10 
 GPx4C37S 
5’-GGTTTCGTGTCCATCGTCACCAACGTGG-3’ 
5’-CCACGTTGGTGACGATGGACACGAAACC-3’ 
Substitution of Cys with 
 Ser at position 37 
 GPx4C66S 
5’-CGATATGCTGAGTCTGGTTTACGAATCC-3’ 
5’-GGATTCGTAAACCAGACTCAGCATATCG-3’ 
Substitution of Cys with 
 Ser at position 66 
 GPx4C75S 
5’-CTGGCCTTCCCCTCCAACCAGTTTGGGA-3’ 
5’-TCCCAAACTGGTTGGAGGGGAAGGCCAG-3’ 
Substitution of Cys with 
 Ser at position 75 
 GPx4C107S 
5’-TGTACAGCAAGATCTCTGTAAATGGGGACGATGC-3’ 
5’-GCATCGTCCCCATTTACAGAGATCTTGCTGTACA-3’ 
Substitution of Cys with 
 Ser at position 107 
 GPx4C148S 
 5’-AAGAACGGCTCCGTGGTGAAGCGCTATG-3’ 
 5’-CATAGCGCTTCACCACGGAGCCGTTCTT-3’ 
Substitution of Cys with 
 Ser at position 148 
 GPx4C168S 
 5’-GACCTGCCGTCCTATCTCTAGCTAGCCC-3’ 
 5’-GGGCTAGCTAGAGATAGGACGGCAGGTC-3’ 
Substitution of Cys with 
 Ser at position 168 
 GPx4Q81A 
 5’-CCAGTTTGGGAGGGCGGAGCCAGGAAGTAATC 
 5’-GATTACTTCCTGGCTCCGCCCTCCCAAACTGG 
Substitution of Gln with 
 Ala at position 81 
 GPx4Q81E 
 5’-CAGTTTGGGAGGGAGGAGCCAGGAAGTA-3’ 
 5’-TACTTCCTGGCTCCTCCCTCCCAAACTG-3’ 
Substitution of Gln with 
 Glu at position 81 
 GPx4W136D 
 5’-GGAAATGCCATCAAAGACAACTTTACCAAGTTTC-3’ 
 5’-GAAACTTGGTAAAGTTGTCTTTGATGGCATTTCC-3’ 
Substitution of Trp with 
 Asp at position 136 
 GPx4N137A 
 5’-GCCATCAAATGGGCCTTTACCAAGTTTCTC-3’ 
 5’-GAGAAACTTGGTAAAGGCCCATTTGATGGC-3’ 
Substitution of Asn with 
 Ala at position 137 
 GPx4N137D 
 5’-GCCATCAAATGGGACTTTACCAAGTTTCTC-3’ 
 5’-GAGAAACTTGGTAAAGTCCCATTTGATGGC-3’ 
Substitution of Asn with 
 Asp at position 137 
 GPx4∆SECIS 
  U46C
 
 5’-GTGGCCTCGCAATGCGGCAAAACTGACGTAAAC-3’ 
 5’-TTTACGTCAGTTTTGCCGCATTGCGAGGCCACG-3’ 
Substitution of Sec with 
 Cys at position 46 
 MlsC16S-  
 GPx4 
 5’-GCCAGCACTGCTGTCCGGGGCTCTGGCTGCG-3’ 
 5’-CGCAGCCAGAGCCCCGGACAGCAGTGCTGGC-3’ 
Substitution of Cys with 
 Ser at position 16 of the 
 Mls 
 NheI-kill 
 5’-CGAGAAAGGAGCCAGCTACCCATACGATGTTCC-3’ 
 5’-GGCGATAGAAGGCGATGCGCTGCGAATCG-3’ 
Deletion of the NheI site  
upstream of GPx4 
 pRTS-GPx4 
 5’-CCAAGGTGATCATTAGGCAGCCAGG-3’ 
 5’-GCGTCGATTTAAATCGCCACCATGG-3’ 
Addition of a BclI restriction site 
upstream and SwaI restriction 
site downstream of GPx4  for 
cloning of FSH-GPx4 or variant  
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Name Sequence Purpose 
 Oligo Mls- 
 GPx4-f1 
 5’-ATTGGATCCGAGATGAGCTGGGGCCGTC-3’ 
introduction of a BamHI site 5’ 
from the Mls 
 Oligo Mls- 
 GPx4-f2 
 5’-CGCCTGGTCTGGCAGGCACCTACCCATACGATGTTC 
CAGA-3’ 
introduction of an overlap 
corresponding to the end of the 
Mls in front of FSH-GPx4 and 
elimination of FSH-tag AUG 
 Oligo Mls- 
 GPx4-f3 
 5’-CGCCTGGTCTGGCAGGCACCGATTATAAAGATGATG 
ATGA-3’ 
introduction of an overlap 
corresponding to the end of the 
Mls in front of HA-GPx4 and 
elimination of HA-tag AUG 
 Oligo Mls- 
 GPx4-r1 
 5’-TCTGGAACATCGTATGGGTAGGTGCCTGCCAGACCA 
GGCG-3’ 
Introduction of an overlap 
corresponding to the beginning 
of the FSH-tag behind the Mls 
 Oligo Mls- 
 GPx4-r2 
 5’-GGCCACGTTGGTGACGATGC-3’ 
amplification of FSH-GPx4 and 
HA-GPx4, respectively 
 Oligo Mls- 
 GPx4-r3 
 5’-TCATCATCATCTTTATAATCGGTGCCTGCCAGACCA 
GGCG-3’ 
Introduction of an overlap 
corresponding to the beginning 
of the HA-tag behind the Mls 
 
All oligonucleotides were obtained from Metabion GmbH, Martinsried, Germany.  
 
 
2.6 Disposables and Kits  
 
Item_____________Company________________________Catalog-No. 
 
DMEM      Invitrogen, Karlsruhe, Germany    41966 
Gel Extraction Kit    QIAGEN GmbH, Hilden, Germany    28704 
Hybond-C super membrane   GE Healthcare, Freiburg, Germany   RPN203G 
Hybond-N+ membrane    GE Healthcare, Freiburg, Germany   RPN303B 
Hyperfilm     GE Healthcare, Freiburg, Germany   RPN3103K 
X-ray film     GE Healthcare, Freiburg, Germany   RPN16778K 
JETstar Plasmid purification system  Genomed GmbH, Löhne, Germany   220020 
LightCycler Capillaries    Roche Diagnostics, Mannheim, Germany   11 909 339 001 
Plasmid Maxi Kit     QIAGEN GmbH, Hilden, Germany    12163 
PCR Cloning Kit     QIAGEN GmbH, Hilden, Germany    231122 
RNeasy Mini Kit    QIAGEN GmbH, Hilden, Germany   74104 
Rediprime II random prime labelling system GE Healthcare, Freiburg, Germany    RPN1633 
Sephadex G-50 columns    GE Healthcare, Freiburg, Germany   27-5330-01 
Sep-Pak C 18 cartridges    Waters GmbH, Eschborn, Germany  WAT051910  
__________________________________________________________________Methods 
 
25 
2.7 Enzymes  
 
Enzyme___________________Company_______________________Catalog-No. 
 
BamHI     Fermentas GmbH, St. Leon-Rot, Germany  ER0051 
BclI     Fermentas GmbH, St. Leon-Rot, Germany  ER0721 
DNA Polymerase I (Klenow)   New England Biolabs GmbH, Frankfurt, Germany  M0210S 
DpnI     Fermentas GmbH, St. Leon-Rot, Germany  ER1701 
EcoRI     Fermentas GmbH, St. Leon-Rot, Germany  ER0271 
HindIII     Fermentas GmbH, St. Leon-Rot, Germany  ER0501 
NheI     Fermentas GmbH, St. Leon-Rot, Germany  ER0971 
NotI     Fermentas GmbH, St. Leon-Rot, Germany   ER0591 
Pfu DNA Polymerase    Promega GmbH, Mannheim, Germany   M774A 
Phosphatase, alkaline    Roche Diagnostics, Mannheim, Germany   713 023 
Proteinase K     Roth Carl GmbH & Co., Karlsruhe, Germany  7528.1 
Restriction Endonucleases   New England Biolabs GmbH, Frankfurt, Germany 
T4 DNA Ligase     Promega GmbH, Mannheim, Germany   M180A 
Taq DNA Polymerase    Invitrogen, Karlsruhe, Germany    18038-026 
XbaI     Fermentas GmbH, St. Leon-Rot, Germany  ER0681 
 
 
2.8 Equipment  
 
Equipment___________________________Company_______________________ 
 
FACS Calibur       BD GmbH, Heidelberg, Germany 
GenAmp PCR system 2700     Applied Biosystems, Darmstadt, Germany 
Gene Pulser II System      Bio-Rad, Munich, Germany 
Gene Pulser Electroporation Cuvettes, 0.4 cm gap   Bio-Rad, Munich, Germany 
Heraeus Incubator, Modell B 5060     Heraeus Holding GmbH, Hanau, Germany 
Leica DM IRBE confocal microscope    Leica Microsystems GmbH, Wetzlar, Germany 
Leica TCS SP2 scanner     Leica Microsystems GmbH, Wetzlar, Germany 
Light-Cycler 1.5       Roche Diagnostics, Mannheim, Germany 
LS 5000 TA Scintillation Counter     Beckman Coulter GmbH, Krefeld, Germany 
Microscope Axiovert 135      Carl Zeiss Jena GmbH, Göttingen, Germany 
Microscope Axiovert 200M     Carl Zeiss Jena GmbH, Göttingen, Germany 
Mini-PROTEAN 3 Electrophoresis Cell    Bio-Rad, Munich, Germany 
Mini-Sub Cell GT Electrophoresis Cell    Bio-Rad, Munich, Germany 
OTD Combi Ultracentrifuge     Sorvall, Langenselbold, Germany 
Photometer Bio       Eppendorf, Hamburg, Germany 
PowerPac 200 Power Supply     Bio-Rad, Munich, Germany 
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Spectrophotometer DU-64     Beckman Coulter GmbH, Krefeld, Germany 
Speed Vac Concentrator SVC100H    Savant Instruments NC, Farmingdale, N.Y. USA 
Trans-Blot Semi-Dry      Bio-Rad, Munich, Germany 
RF-10A XL Fluorescence Spectrophotometer   Shimadzu, Duisburg, Germany 
UZ-PA-38,5-1 Ultracentrifuge Tubes    Kisker GbR, Steinfurt, Germany 
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2.9   Expression vectors  
 
442-PL1 
 
 
Figure7: Map of the lentiviral expression vector p442-PL1. ampR (beta lactamase), RU5 (RU5 LTR), PBS 
(primer binding site), RRE (Rev responsive element), PPT (poly-purine tract), SFFVp (spleen focus forming virus 
promoter), BamHI/XbaI (restriction sites used for cloning), IRES (internal ribosome entry site), PL1nucmem 
(fluorescent protein with nuclear membrane anchor), PRE (post regulatory element), SIN (self-inactivating 3’ 
LTR). 
 
pDrive 
 
Figure 8: Map of the expression vector pDrive. (Qiagen, Hilden). MCS (multiple cloning site) containing BamHI  
and XbaI restriction sites used for cloning, Ampicillin resistance (beta lactamase) and Kanamycin resistance 
(kanamycin kinase gene). 
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3 Methods 
 
3.1 Cell culture and related techniques 
 
3.1.1 Murine embryonic fibroblasts (MEFs) 
MEF cells were cultured with standard DMEM medium at 20 % O2 and 5 % CO2. Cells were 
splitted every second to third day, depending upon confluency, at a 1:10 ratio.  
 
Standard DMEM: DMEM, 4.5 g/l glucose, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml 
streptomycin 
 
3.1.2 Determination of cell number 
Cells were harvested from cell culture dishes by trypsinization and suspended by adding 5 
volumes of Standard DMEM. 30 µl of the cell suspension was mixed with an equal volume of 
0.4 % trypan blue solution and cells were counted using a Fuchs-Rosenthal 
haemocytometer. Trypan blue is excluded from viable cells, whereas dead cells stain blue 
due to plasma membrane disruption. 
 
Standard DMEM: DMEM, 4.5 g/l glucose, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml 
streptomycin 
 
3.1.3 Cryopreservation and thawing of cells 
Stocks of all cell lines were stored in liquid nitrogen. Cells were grown in 10 cm cell culture 
dishes until they reached approximately 80 % confluency. Cells were washed with PBS 
trypsinized and collected by centrifugation. The cell pellets were resuspended in FCS 
containing 10 % DMSO, transferred to cryo vials in 1 ml aliquots and frozen in isopropanol 
containers at -80 °C over night. Subsequently, vials were transferred to a liquid nitrogen tank. 
Frozen cells were defrosted in a water bath at 37 °C, immediately transferred to 5 ml 
Standard DMEM and collected by centrifugation. Cell pellets were resuspended in 10 ml 
Standard DMEM and seeded onto a 10 cm cell culture dish. 
 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 4.5 g/l glucose, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml 
streptomycin 
 
__________________________________________________________________Methods 
 
29 
3.2 Gene transfer methods 
 
3.2.1 Lentiviral infection 
Lentivirus-based gene transfer methods mediate an efficient gene transfer into primary cells. 
The lentiviral infection method proved to be the most efficient technique to transfer DNA into 
immortalised MEFs due to integration and stable expression of transgenes in dividing as well 
as resting cells. Lentiviral particles were produced in HEK 293 T packaging cells with a third 
generation lentiviral packaging system, which provides maximal biosafety. Yet this method is 
more laborious, because it involves the simultaneous transfection of four different plasmids 
into the producer cell line. Three plasmids encode all necessary structural proteins for 
lentivirus production, including pEcoEnv-IRES-puro (contains glycoprotein Env), plasmid 
pMDLg_pRRE (contains the main structural protein Gag and the enzyme cluster Pol) and 
pRSV_Rev (contains the post-transcriptional regulator Rev). Third generation packaging 
systems are Tat independent, because the transfer vector pRRL.PPT.SF.IRES-
VENUSnucmem (p442) contains an additional SFFV promoter. 5 x 106 HEK 293 T packaging 
cells were seeded in Standard DMEM on 10 cm cell culture dishes and incubated for 24 h. 
Plasmids (2 µg pEcoEnv-IRES-Venus, 5 µg pMDLg_pRRE, 10 µg pRSV_Rev, 5 µg p442-
PL1-based vectors) were diluted in 500 µl 12.5 mM CaCl2 solution and mixed with 500 ml 
HBS by air bubbling. Cell culture medium was replaced with TF medium, and chloroquine 
was added to a final concentration of 25 µM. For calcium phosphate transfection, the plasmid 
mix was vortexed, applied to the cell culture dish, and the cells were incubated for 8-12 h. 
The transfection medium was replaced with fresh TF medium and the transfected packaging 
cells were incubated for further 36 h. Virus-enriched TF medium was recovered from the cell 
culture dish, filtrated through a 0.22 mm sterile filter and centrifuged in a swing rotor 
ultracentrifuge for at least 16 hours at 16,000 x g. The virus containing pellet was 
resuspended in 200 µl Standard DMEM and stored at -80 °C. 3 x 105 MEFs were infected in 
a 3.5 cm cell culture dish by adding 50 µl of the virus concentrate and a subsequent 
incubation for 48 h. Infection efficiency was monitored by fluorescence microscopy, 
screening for VENUSnucmem expression and quantification was performed by FACS 
analysis. 
 
Chloroquine (1000x): 25 mM chloroquine in PBS 
HBS (2x): 50 mM HEPES, 280 mM NaCl, 1.5 mM Na2HPO4, pH 7.05 adjusted with NaOH 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 4.5 g/l glucose, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml 
streptomycin 
TF medium: Standard DMEM, 20 mM HEPES 
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3.2.2 Electroporation 
 
3.2.2.1 Transfection of mammalian cells by electroporation 
Cells were harvested by trypsinization, washed twice in PBS and resuspended in 250 µl 
FCS-free DMEM. Primary MEFs (1 x 106 cells) were electroporated with a Gene Pulser II 
(Bio Rad, Munich, Germany) in cuvettes with 0.4 cm gap width. For each transfection, 20 µg 
of linearized plasmid DNA were transfected into cells with an electric pulse of 230 V and a 
capacitance of 940 µF. FCS (500 µl) was applied to the cells immediately after the pulse. 
The cell suspension was gently mixed by pipetting, and cells were seeded on a 10 cm cell 
culture dish in Standard DMEM. Selection was initiated 24 hours after electroporation by the 
addition of 150 µg/ml G418. 
 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 4.5 g/l glucose, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml 
streptomycin 
 
3.2.2.2 Transformation of bacterial cells (XL1-Blue ) by electroporation  
Twenty µl of electro-competent cells were transferred into a pre-cooled 1.5 ml Eppendorf 
tube. 1-2 µl of diluted DNA was added to the bacteria, mixed briefly and transferred to a 1 
mm cuvette. Cells were pulsed with 1.5 (KV), 25 µF and 100 Ohm. Immediately after pulsing, 
1 ml of SOC medium was added to the cuvette. The cells were shaken shortly and then 
incubated at 37 °C for 30 min. After incubation, the cells were centrifuged for 2 min at 
700 x g. Most of the supernatant was discarded and the bacteria were resuspended in the 
remaining SOC medium. Cells were platted on two LB agar plates at either 10 % or 90 %, of 
the resuspended bacteria, respectively, and plates were incubated over night at 37 °C. 
 
SOC medium: 20 g Bacto Tryptone, 5 g Bacto Yeast Extract, 2 ml of 5 M NaCl, 2.5 ml of 1 M KCl, 10 
ml of 1 M MgCl2, 10 ml of 1 M MgSO4, 20 ml of 1 M glucose adjust to 1 l with dH2O 
Ampicillin: 100 µg/ml 
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3.3 Cloning techniques 
 
3.3.1 Preparation of competent cells 
Competent cells were prepared by the rubidium chloride procedure using DH5α E. coli cells. 
250 ml LB medium containing 20 mM MgSO4 were inoculated with a single colony from an 
LB plate and incubated over night at 37 °C with shaking until the OD600 reached 0.4-0.6. 
Cells were collected at 4,500 x g for 5 min at 4 °C. All subsequent steps were performed in a 
4 °C cold room with pre-chilled pipettes, tubes and flasks. Cells were resuspended in 100 ml 
of ice cold TFB1, incubated on ice for 5 min and pelleted at 4,500 x g for 5 min at 4 °C. Cells 
were resuspended gently in 10 ml TFB2, incubated on ice for 30 min and 200 µl aliquots 
were snap-frozen in liquid nitrogen. Aliquots of competent cells were stored at -80 °C. Cells 
were used no longer than 4 months after preparation. 
 
LB: yeast extract (5 g/l), tryptone (10 g/l), NaCl (0.5–10 g/l), pH 7 
TFB1: 30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15 % glycerol, pH 5.8 
TFB2: 10 mM 3-(N-morpholino) propansulfonic acid (MOPS), 75 mM CaCl2, 10 mM RbCl, 
15 % glycerol, pH 6.5 
 
3.3.2 Transformation of bacteria by heat shock 
For transformation, 200 µl aliquots were defrosted on ice and 10 µl of the ligation mix or 10 
ng purified plasmid DNA were added to the cell suspension. Cells were incubated for 15 min 
on ice, heated to 42 °C for 90 sec and replaced on ice for 2 min. 800 µl LB medium were 
added to the cell suspension and incubated for 45 min at 37 °C with vigorous shaking. All 
plasmids used in this work contained a beta lactamase cassette for selection. 100 µl of the 
transformation mixture was plated on a LB plate containing 50 µg/ml ampicillin. Remaining 
cells were harvested by brief centrifugation at 10,000 x g for 20 sec to remove excess LB. 
The pellet was resuspended in 100 µl LB and plated onto a second LB plate with ampicillin. 
Agar plates were incubated for 12-20 hours at 37 °C until single cell colonies became visible. 
 
LB: yeast extract (5 g/l), tryptone (10 g/l), NaCl (0.5–10 g/l), pH 7 
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3.3.3 Preparation of plasmid DNA 
After transformation, single colonies were picked from LB plates and used to inoculate 2 ml 
LB medium, containing 50 µg/ml ampicillin. The inoculum was incubated at 37 °C for 12-20 
hours with shaking. Cells were harvested by centrifugation at 10.000 x g for 20 sec and 
resuspended in 200 µl buffer E1 by vortexing. 200 µl of denaturing buffer E2 was added to 
the cell suspension, mixed by inverting the tube and incubated for 5 min at room 
temperature. To stop the denaturation reaction, 200 µl of buffer E3 was added, mixed by 
inverting and centrifuged for 6 min at 10,000 x g. To extract proteins and lipids, 400 µl of 
phenol-chloroform was added, vortexed and centrifuged for 3 min at 10,000 x g. Plasmid 
DNA dissolves in the aqueous upper phase, which was recovered and added to 500 ml 
isopropanol for DNA precipitation. The precipitated DNA was harvested by centrifugation for 
12 min at 4 °C at 10,000 x g. The DNA pellet was washed with 70 % ethanol, dried for 30 min 
at room temperature and resuspended in 50 µl TE. The purified plasmids were subjected to 
analytic restriction digestions to identify the correct construct and orientation of the insert. 
After identification of the correct clones, selected single cell clones were used to augment 
plasmid DNA according to Qiagen Plasmid Maxi Kit instructions. Plasmid concentrations 
were determined by measuring the absorbance at 260 nm in a spectrophotometer. 
 
E1: 50 mM Tris, 10 mM EDTA, pH 8,0 
E2: 200 mM NaOH, 1 % (w/v) SDS 
E3: 3.1 M potassium acetate, adjust to pH 5.5 with acetic acid 
TE: 10 mM Tris pH 7.5, 1 mM EDTA 
 
3.3.4 Isolation of DNA fragments 
DNA restriction digestion was performed with respective endonucleases according to 
manufacturers’ instructions (New England Biolabs GmbH or MBI Fermentas GmbH). DNA 
fragments were separated by electrophoresis in a 0.8 % low melting point (LMP) agarose gel 
at 60 V in 1 x TAE buffer. The desired fragment was isolated from the gel with a scalpel and 
processed by phenol-butanol-DNA extraction as follows. Isolated LMP-gel-fragments were 
melted at 68 °C for 10 min. After melting, 300 µl of pure phenol were added and briefly mixed 
and centrifuged for 6 min at 10,000 x g. The upper aqueous phase was recovered and the 
volume was reduced to 50 µl by butanol extraction. The butanol phase was removed and 
DNA was precipitated by adding 2.5 x volumes of ethanol and 50 mM NaCl, followed by 
centrifugation at 4 °C with 10,000 x g. The DNA precipitate was washed with 70 % ethanol, 
centrifuged as above and air-dried for 30 min. The dried DNA pellet was dissolved in 30 µl 
TE and stored at -20 °C. 
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TAE (50x): 2 M Tris-acetate (2 M Tris-base and 5.71 % v/v acetic acid); 50 mM EDTA/NaOH pH 8.0 
TE: 10 mM Tris pH 7.5; 1 mM EDTA 
 
3.3.5 Phenol-chloroform extraction and ethanol precipitation of DNA 
Linearized fragments, obtained from restriction enzyme digestions, were purified by phenol-
chloroform treatment and subsequent ethanol precipitation. Therefore, an equal volume of 
phenol-chloroform-isoamylalcohol was added to the digestion reaction, briefly mixed and 
centrifuged for 6 min at 10,000 x g. The upper aqueous phase was recovered and DNA was 
precipitated by adding 2.5 x volumes of ethanol and 50 mM NaCl, followed by centrifugation 
at 4 °C with 10,000 x g. The DNA precipitate was washed with 70 % ethanol, centrifuged as 
above and air dried for 30 min. The dried DNA pellet was dissolved in 30 µl TE and stored at 
-20 °C. 
 
TE: 10 mM Tris pH 7.5, 1 mM EDTA 
 
3.3.6 DNA ligation 
Ligation reactions were prepared with T4 DNA ligase according to standard procedures, 
described in the manufacturers’ instructions (Promega GmbH). The solutions contained       
3-5 ng vector and 5-10 ng insert DNA and were incubated at a 16 °C – 0 °C gradient for     
12-24 hours. To quantify the specificity of the ligation reaction, respective backbone and 
insert DNA were subjected to separate control ligations. The ligation reactions were used for 
subsequent heat shock transformation of chemically competent bacteria. 
 
TE: 10 mM Tris pH 7.5, 1 mM EDTA 
 
3.3.7 Dephosphorylation of linearized plasmid DNA 
Vector DNA was dephosphorylated with alkaline phosphatase according to manufacturers’ 
instructions (Roche Diagnostics). Dephosphorylation of backbone DNA favours the 
integration of DNA inserts since religation of the backbone is prevented. After 
dephosphorylation, DNA fragments were purified by phenol-chloroform extraction as 
described above. The standard procedure was incubation for 1 hour at 37 °C. 
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3.4 Cloning of expression vectors 
 
3.4.1 Site-directed PCR Mutagenesis 
Mutations of single amino acids within GPx4 were performed by site-directed PCR 
mutagenesis with pDrive-Flag-Strep-HA-GPx4 as a template (Seiler, Schneider et al. 2008) 
in a volume of 50 µl. Primers of 30-33 nucleotides were designed, such that the primer 
sequence consists of a mutated codon, flanked by wild type sequences of at least 10 
nucleotides. Mutated codons were chosen according to the highest murine codon usage of 
the respective amino acid. The codon substitution used is shown in Table 5. The PCR-
reactions were performed with reduced primer annealing temperature depending on the 
substitution used, due to the mismatch of primer and wild type GPx4 sequence. The list of 
primers used can be found in the Materials section. Prior to the transformation of competent 
cells, PCR reactions were digested with DpnI for 60 min to remove methylated template 
DNA. Mutations were verified by sequencing in pDrive with primers ”T7 promoter” and “SP6 
promoter”. The mutated sequences were cloned in the lentiviral expression vector p442-PL1 
as described above, yielding the according p442-FSH-GPx4-variants. Products were 
sequenced again to ascertain the correct coding sequence. 
 
Tabel 5: The different codon substitutions used to replace the corresponding amino acid. 
 Nomenclature  Mutation  Nomenclature  Mutation 
 GPx4 
 sequence see Materials  GPx4All Cys
 
 From GeneArt 
 GPx4U46C 
 TGA → TGC  GPx4Q81A  CAG → GCG 
 GPx4U46S 
 TGA → AGC  GPx4Q81E  CAG → GAG 
 GPx4C2S 
 TGT → TCT  GPx4W136D  TGG → GAC 
 GPx4C10S 
 TGT → TCT  GPx4N137A  AAC → GCC 
 GPx4C37S 
 TGT → TCC  GPx4N137D  AAC → GAC 
 GPx4C66S 
 TGT → TCT  GPx4∆SECIS  none 
 GPx4C75S 
 TGC → TCC  GPx4∆SECIS U46C  TGA → TGC 
 GPx4C107S 
 TGT → TCT  Mls-GPx4  none 
 GPx4C148S 
 TGC → TCC  Mls-GPx4U46C  TGA → TGC 
 GPx4C168S 
 TGC → TCC  MlsC16S-GPx4  TGC → TCC 
The positions of the respective codons are marked in Materials 2.5 
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3.4.2 Generation of the Mls-FSH-GPx4 
The mitochondrial localization signal (Mls) was introduced upstream of the FSH-GPx4 by 
overlap and extension PCR using the following primers: Oligo Mls-GPx4-f1, Oligo Mls-GPx4-
f2, Oligo Mls-GPx4-f3, Oligo Mls-GPx4-r1, Oligo Mls-GPx4-r2 and Oligo Mls-GPx4-r3. The 
isolation of the Mls sequence from genomic DNA was the first step. For the second step the 
appropriate restriction site (BamHI) was added at the 5’-end and a 20 bp sequence 
representing the start of the FSH-GPx4 was added at the 3’-end. These base-pairs included 
a substitution of the start codon (AUG) with an ACG sequence. The FSH-GPx4 was isolated 
from the pDrive plasmid. For this cloning step the start codon was replaced as described 
above and a 20 bp overhang was added to the 5’-end representing the last 20 bp of the Mls-
sequence. Both fragments were purified and isolated by LMP gel electrophoresis and 
subsequent phenol-butanol extraction. Both purified fragments were used as templates for 
the overlapping PCR. The resulting overlap PCR product was sequenced after cloning into 
pDrive. Thereafter, the construct was transferred in the lentiviral expression vector as 
described below. 
 
3.4.3 Generation of SECIS-less GPx4 
 
The GPx4 SECIS element was predicted by using Seleno DB (www.selenodb.org, 
SPS00000047). The pDrive vector carrying either WT or U46C, which contains two NheI 
restriction sites flanking the SECIS element, was digested with NheI. After digestion, the 
linearized vectors were isolated, religated and cloned. This led to the generation of SECIS-
less wild type (WT) and U46C cDNA´s.  
 
3.4.4 p442-PL1-based GPx4 expression vectors  
The 3rd generation lentiviral vector p442-PL1 (a kind gift from Dr. Timm Schröder, Helmholtz 
Zentrum München, Munich, Germany) was used for efficient gene transfer and expression in 
mosue embryonic fibroblasts (MEFs) by viral infection. Gene expression in p442-PL1 is 
regulated by an SFFV promoter, synthesizing a bicistronic mRNA that is linked by an internal 
ribosome entry site (IRES). The fluorescence marker VENUSnucmem including a nuclear 
membrane anchor (nucmem) is encoded at the 3’ position of the bicistronic expression 
cassette. As described below, various genes were cloned into the 5’ position of the 
expression cassette, upstream of the IRES. 
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3.5   Immunoblotting and Immunocytochemistry 
 
3.5.1 Western blot 
For whole cell lysate preparation, cells were lysed in LCW Lysis Buffer, containing Protease 
Inhibitor Cocktail (Roche Diagnostics), sonicated (Duty cycle set at 80,  
Output set at 10) for 40 sec and incubated for 30 min on ice. Cell debris was removed by 
centrifugation for 30 min at 4 °C at 15,000 x g. Protein concentration of the supernatant was 
determined by the DC Protein Assay (Bio-Rad), according to manufacturers’ instructions. 
Equal amounts of protein lysates were mixed with sample loading buffer, boiled for 5 min at 
95 °C, and proteins were separated on a 12 % SDS-PAGE at 160 V in a Mini-PROTEAN 3 
Electrophoresis Cell (Bio-Rad, Munich, Germany). Proteins were transferred onto a Hybond-
C super nitrocellulose membrane in blotting buffer with a Trans-Blot Semi-Dry Blotter at 20 V 
for 30 min (Bio-Rad, Munich, Germany). Membranes were blocked with 5 % skim milk 
powder in TBST for 30 min and probed with a primary antibody at 4 °C for at least 12 hours. 
Membranes were washed three times in TBST for 5 min, following HRP-conjugated 
secondary antibody incubation for 60 min. The nitrocellulose membranes were repeatedly 
washed in TBST (3 x 5 min) and proteins were visualized by ECL detection on Hyperfilm. 
Efficient stripping of Hybond-C super membranes was performed with 0.4 M NaOH for 
10 min. Prior to second incubation (usually with a primary antibody against β-Tubulin), 
membranes were blocked with 5 % skim milk powder in TBST for 60 min. All following steps 
were performed as described above. 
 
Blotting buffer: 10 % running buffer (10x), 20 % methanol 
Sample loading buffer (2x): 100 mM Tris, 4 % SDS, 20 % glycerol, 0.1 % bromophenol blue, 
100 mM DTT, pH 6.8 
LCW lysis buffer: 0.5 % TritonX-100, 0.5 % sodium deoxycholate salt, 150 mM NaCl, 20 mM TRIS, 
10 mM EDTA, 30 mM Na-pyrophosphate, pH 7.5 
Running buffer (10x): 250 mM TRIS, 1 % SDS, 2.5 M glycine 
TBST: 25 mM TRIS, 125 mM NaCl, 0.1 % Tween-20, pH 8.0 
 
3.5.2 Determination of relative protein amount 
In order to be able to compare the different protein expression levels of every variant of 
GPx4, a semi-quantitative approach using immunoblotting data was used. Protein was 
extracted from cells and used in a dilution series (1:4). Resulting western blot results were 
analyzed by Image J software and normalized to internal β-tubulin controls.  
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3.5.3 Immunocytochemistry and confocal microscopy 
MEFs were seeded on UV-sterilized and ethanol-cleaned cover slips in 6-well cell culture 
dishes. Cells were cultivated to semi-confluency in standard DMEM. Cells were incubated for 
30 min with a 100 nM solution of Mitotracker Red CMXRos in serum free DMEM and washed 
3 x 5 min with medium. For fixation of adherent cells, medium was aspirated from the cell 
culture dish, and cover slips were rinsed with PBS. Cells were fixed for 10 min in a 4 % PFA 
solution. Cover slips were washed 3 x with PBS and permeabilized for 3 x 5 min with 0.1 % 
Triton X-100 in PBS. Subsequently, cells were blocked for 3 x 15 min with 1 % BSA in PBS. 
For detection of FSH-tagged GPx4, cover slips were incubated over night with the primary 
antibody α-Flag High Affinity (Sigma M2) at 4 °C in a humidified chamber. Glasses were 
washed 3 x 10 min with PBS/Tween and subsequently incubated with the secondary 
antibody α-rabbit-Cy5 conjugate protected from light (45 min). Cover slips were washed 3 x 
10 min with PBS/Tween and then incubated for 10 min in DAPI solution. Glasses were briefly 
rinsed in PBS and mounted onto microscope slides, using VECTASHIELD® Mounting 
Medium. Excess liquid was removed and slides were sealed with nail polish and stored at 
4 °C. Pictures were taken by confocal-laser microscopy with Leica DM IRBE microscope, 
Leica TCS SP2 scanner and Leica Confocal software. 
 
α-FSH (Sigma M2) antibody solution: 1:200 dilution in 1 % (w/v) BSA in PBS 
α-rabbit-Cy5 solution: 1:200 dilution in 1 % (w/v) BSA in PBS 
Mitotracker Red CMXRos:  100 nM in serum free DMEM  
DAPI-solution: 1 µg/ml DAPI diluted in PBS (5 mg/ml stock solution in H2O) 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
PBS/Tween: 0.1 % (v/v) Tween 20 in PBS 
PFA solution: 4 % (w/v) PFA in PBS, pH 7.4 adjusted with HCl 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
Triton X-100 solution: 0.1 % (v/v) Triton X-100 in PBS 
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3.6  Flow cytometry (FACS analysis) 
 
3.6.1 Determination of infection efficiency by flow cytometry 
Cells were harvested from an 80 % - 90 % confluent 6 well. Cell were trypsinised and 
transferred into medium, collected by centrifugation for 5 min at 1200 rpm. Supernatant was 
aspirated, and cells were washed once in PBS. After centrifugation cells were resuspended 
in PBS containing 1 % FCS. Resuspended cells were applied to a flow cytometry, whereby 
cell suspensions were excited with 488 nm UV line argon ion laser and Venus emission was 
recorded on channel FL1 at 524 nm. 
 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
 
3.6.2 Cell viability detection by flow cytometry 
Cell viability was determined by propidium iodide (PI) staining. The fluorogenic dye PI enters 
only dead cells and intercalates into double stranded DNA. PI does not cross the intact 
membrane of viable cells, thus its fluorescence of above 630 nm can be used as a measure 
for cell viability. Adherent cells were washed with PBS and trypsinized. Cells were collected 
by centrifugation (180 x g, 5 min), washed in PBS three times and resuspended in 200 µl 
PBS. PI was added to a final concentration of 1 µg/ml. Cell suspensions were excited with 
488 nm UV line argon ion laser and PI emission was recorded on channel FL3 at 661 nm.  
 
PI solution: 1 mg/ml PI in PBS 
PBS: 80.0 g NaCl, 2.0 g KCL, 14.4 g Na2HPO4, 2.4 g KH2PO4 in 1 l H2O, pH 7.4 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
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3.7   GPx4-specific activity 
 
3.7.1 Substrate Preparation 
Phosphatidylcholine hydroperoxide (PCOOH) was generated by oxygenation of 
phosphatidylcholine catalysed by lipoxygenase. This enzyme has the capability to act on 
phospholipids provided that deoxycholate is present. After a given incubation of 
phosphatidylcholine with lipoxygenase in the presence of deoxycholate, deoxycholate was 
removed and PCOOH concentrated by solid phase extraction. 
Oxygenation of PCOOH was started by adding 200 µl of soybean lipoxygenase 
(corresponding to 660 U) to the incubation mixture. After 20 min continuous stirring, the 
whole mixture was loaded onto reverse phase Sep-Pak C 18 cartridges (Waters GmbH), and 
purified via reverse phase HPLC. Prior to loading, the cartridges were equilibrated with 5 ml 
methanol followed by 10 ml H2O. After loading, the cartridge was washed with 20 ml H2O and 
then air-dried. PCOOH was eluted with 1.5 ml of methanol. The first drop of the eluate was 
discarded as it contained most of the deoxycholate still bound to the matrix. PCOOH 
methanolic solution was stored at -20 °C, where it is stable for several months. During 
storage, a white precipitate may appear. This is mostly deoxycholate, which was not 
eliminated during the procedure described above, but can be removed by centrifugation. 
PCOOH was quantified by measuring the total NADPH consumption after adding 15-30 µl 
methanolic solution as substrate. Calculations were made by using E(NADPH)= 6.22 mM-1cm-1. 
 
Buffer: 0.2 M Tris-HCl, pH 8.6, 3 % Na-deoxycholate (DOC), 39 mg soy bean phosphatidylcholine, 
(PC), SIGMA cat. P-6263) dried and mixed with 1 ml DOC 3 % 
HPLC grade methanol, PCOOH 
Incubation mixture: 24.37 ml Tris buffer, 170 ml PC, 2.26 ml DOC 
Soybean Lipoxygenase type IV: SIGMA cat. L-3004 
SEP Pack C18: Reverse phase cartridges for solid phase extraction (Waters-Millipore c51910) 
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3.7.2 Measurement of GPx4-specific activity 
GPx4 activity was measured through recording the specific NADPH oxidation at 340 nm in 
the presence of GSH, GSSG reductase, and phosphatidylcholine hydroperoxides, according 
to published protocols (Ursini, Maiorino et al. 1985; Zhang, Maiorino et al. 1989; Maiorino, 
Gregolin et al. 1990). A stirrer was used to improve the quality of recording. 200 µl of whole 
cell lysate containing GPx4 was added to 0.5 ml of the prepared mixture as described below. 
The volume was adjusted to 2.5 ml by addition of dH2O in order to achieve the following final 
concentrations: 0.1 M Tris-HCl, 5 mM EDTA, 0.16 mM NADPH, 1 mM NaN3, 3 mM GSH, 
0.1 % Triton X-100, 1 U/ml Glutathione reductase. After recording of the baseline, reaction 
was started with 15-30 µl of methanolic solution including PCOOH, prepared as described 
(3.7.1). A volume of 8 µl PCOOH was chosen in order to have a minimal concentration of 
approx. 0.016 mM PCOOH.  
 
Tris-HCl: 1 M, pH 7.4 
EDTA: 0.5 M, pH 8.0 neutralization (with NaOH) is required for solution 
NADPH: 10 mM 
NAN3: 0.1 M 
GSH: 0.1 M 
Glutathione reductase: SIGMA cat. G-4759 
Triton X-100: 20 % 
Mixture for 20 assays: 5 ml Tris-HCl, 0.5 ml EDTA, 0.8 ml NADPH, 0.5 ml NaN3, 1.5 ml GSH, 
0.25 ml Triton X-100, 2.5 U/ml Glutathione reductase, 1.4 ml dH2O 
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3.8   MTT Assay 
 
3.8.1 Determination of cell viability by MTT assay 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma M-5655) is a 
yellow tetrazole and in living cells it is reduced by the mitochondrial reductase, thereby 
forming the insoluble purple formazan. For the MTT assay, cells were plated on a 96 well 
dish containing 90 µl of cell culture medium in a given concentration and incubated for 4 
hours at 37 °C after the addition of 10 µl of MTT reagent. The reaction was terminated by 
adding 200 µl of acidified isopropanol, a solubilisation solution that is needed to dissolve the 
otherwise insoluble purple formazan product into a colored solution. The solubilisation is 
greatly enhanced by repeatedly pipetting up and down the solution followed by gently 
shaking at RT for 1-2 hours. The absorbance (OD) was measured in an ELISA reader at 570 
nm (650 nm reference). Raw data was imported in Excel and statistical analysis was done by 
Sigmastat 3.0. 
 
Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
MTT solution: 5 mg/ml MTT in PBS 
Acidified isopropanol: 0.04 M HCl in isopropanol 
 
3.8.2 Toxicity assays 
Four different toxins, hydrogen peroxide (H2O2, an oxidative stress inducing ROS), tertiary-
butyl hydroperoxide (tBOOH, an oxidative stress inducing ROS), L-buthionine sulfoximine (a 
potent and specific inhibitor of γ-glutamylcysteine synthetase) and doxorubicin (an 
anthracycline antibiotic that works by intercalating into DNA/RNA thereby inhibiting DNA and 
RNA synthesis; it also inhibits the topoiosomerase II enzyme, thereby preventing the 
relaxation of supercoiled DNA and thus blocking DNA transcription and replication) were 
used in five different concentrations to determine the resistance of the different GPx4 
variants: H2O2 (0; 50; 100; 200; 250; 500 µM), tBOOH (0; 1; 5; 10; 20; 50 µM), BSO (0; 0.75; 
1.5; 2; 3.5; 5.5 µM) and doxorubicin (0; 0.5; 1; 2; 5; 10 µM). Cells expressing the different 
GPx4 variants were plated on a 96 well dish in a concentration of 4000 cells/well and were 
left for 4 hours to adhere to the plate. After 4 hours, cell stress was applied by replacing the 
medium by medium containing the different compounds. This was considered as time point 0 
hours. Viability of the cells was measured 0 hour, 24 hours and 48 hours after toxin treatment 
by the MTT assay. 
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Standard DMEM: DMEM, 10 % FCS, 1 % glutamine, 50 U/ml penicillin G, 50 µg/ml streptomycin 
MTT solution: 5 mg/ml MTT in PBS 
H2O2: stock solutions of 50, 100, 200, 250 and 500 mM 
tBOOH: stock solutions of 1, 5, 10, 20 and 50 mM 
BSO: stock solutions of 0.75, 1.5, 2, 3.5 and 5.5 mM 
Doxorubicin: stock solutions of 0.5, 1, 2, 5 and 10 mM 
 
 
3.9   Tet-inducible expression system 
The WT and the U46C constructs were cloned in the pRTS1 vector (Bornkamm, Berens et 
al. 2005) using the SwaI and BclI restriction sites. Pfa1 cells were transfected with the 
construct by electroporation and selected by hygromycin (100 µg/ml) for 3 weeks following 
transfection. After selection, the cells were treated with tamoxifen to induce the GPx4 
knockout. At the same time, doxycycline (dox) was added at 10 nM to the medium to prevent 
cell death induced by disruption of the endogenous GPx4 gene. Dox was washed out by 
several washing steps, and cells were then cultivated with different amounts of dox from up 
to 1 µM to induce different levels of expression of WT and U46C, respectively.   
 
 
3.10  Determination of mRNA levels 
 
3.10.1 RNA isolation and cDNA synthesis 
Total RNA from cells was isolated by RNeasy Mini Kit (Quiagen) according to manufacturers’ 
instructions. Cells were harvested from 10 cm cell culture plates with a cell scraper. 
Disruption of cells occurred by addition of 600 µl Buffer RLT which contains 10 µl/ml 2-ME. In 
order to avoid DNA contamination the accessory RNase-Free DNase Set (Qiagen) was 
used. RNA was eluted with 30 µl of elution buffer from the column. Final RNA concentration 
was determined by measureing the absorbance at 260 nm in a spectrophotometer. The 
Reverse Transcription System (Promega) was used according to manufacturers’ instructions 
on 1 µg of isolated mRNA in order to yield single-stranded cDNA. To increase the yield of 
cDNA the incubation time was prolonged to 45 min.  The cDNA amplification was performed 
with random primers at 42 °C. The initial 20 µl first strand cDNA synthesis reaction mix was 
finally diluted to 100 µl with nuclease-free waterand subject to qRT-PCR 
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3.10.2 Quantitative RT-PCR 
The synthesized cDNA was amplified and detected with LightCycler FastStart DNA 
MasterPLUS SYBR Green I Kit together with LightCycler 1.5 System (Roche). Each qRT-
PCR reaction was composed as follows, 1 µl Master Mix, 1 µl primer mix, 6 µl H2O and 2 µl 
cDNA which were replaced by H2O in the H2O control. Liquids were mixed in a LightCycler 
Capilary and were pre-cooled in a centrifuge adapter. Primers for the qRT-PCR were 
designed to yield 200-300 nucleotide long products of GPx4 RNA (Forward 5’-
GCAACCAGTTTGGGAGGCA GGAG-3’; Reverse 5’-CCTCCATGGGACCATAGCGCTTC-
3’). H2O control was used to detect potential primer dimerization.  
 
Primer Mix: 5 µl of 100 µM forward primer, 5 µl of 100µM reverse primer, 90 µl H2O  
TE: 10 mM Tris pH 7.5; 1 mM EDTA 
 
 
3.11   Statistics 
Statistics were performed using SigmaPlot software and Man-Whitney U-tests and ANOVA 
on ranks respectively. Significant results were marked with an asterisk (<0.05); highly 
significant results with two asterisks (<0.001). 
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4 Results 
4.1 The role of the catalytically active Sec and the remaining Cys 
residues in mammalian glutathione peroxidase 4 (GPx4) 
 
4.1.1 Generation and expression of various mutant forms of the short 
form of GPx4 in inducible GPx4 null cells 
 
In order to address the supposedly essential role of the catalytically important Sec in one of 
the most important mammalian selenoproteins, a recently established inducible GPx4 
knockout cell system was used (Figure 9 A) (designated as PFa1 cells in the following 
(Seiler, Schneider et al. 2008)). PFa1 cells harbour two loxP-flanked GPx4 alleles and stably 
express the MerCreMer (Mer = mutated estrogen receptor) fusion protein. Only upon 4-
hydroxy-tamoxifen (Tam) administration, MerCreMer is liberated from the cytosolic hsp90 
complex and translocates to the nucleus, where Cre-mediated deletion of both GPx4 alleles 
is induced. 
 
 
Figure 9: Schematic representation of the cellular system used for inducible disruption of GPx4-/- (PFa1 
cells) for the in vivo analysis of the GPx4 mutant forms. (A) Shown is the Tamoxifen (Tam)-inducible GPx4 
knockout system in MEFs. Addition of Tam (grey balls) to the cell culture medium, liberates MerCreMer (Mer = 
mutated estrogen receptor) from cytosolic hsp90 (Verrou, Zhang et al. 1999), and thus allows MerCreMer to 
translocate to the nucleus, where Cre-mediated deletion of the last three loxP-flanked (fl; white triangular) exons 
(black bars) occurs. This leads to disruption of the GPx4 allele (Seiler, Schneider et al. 2008). (B) Depicted is the 
relative position of the mutated codons within the GPx4 mRNA.  
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To study the functional relevance of distinct GPx4 residues in vitro, a highly efficient 
lentivirus-based add-back system was used in combination with the inducible GPx4-/- cells. 
Various mutant forms of GPx4 were generated and expressed in these cells (Figure 9 B). For 
detection and purification of potential GPx4 binding partners, all mutant forms were              
N-terminally tagged with an FSH tag (Gloeckner, Boldt et al. 2007). The FSH tag consists of 
Flag-Strep-linker-Strep-HA domains. To be able to detect the expression of the different 
mutant forms of GPx4 in these cells, WT GPx4 and all mutants were expressed in a bi-
cistronic manner using VENUS, a yellow fluorescent protein, as a detectable marker. 
The first set of substitutions was introduced in order to address the catalytically active site 
Sec in GPx4. Sec was mutated either to a Cys (U46C) or a Ser (U46S) residue at this 
position. Cells reconstituted with FSH-tagged wild-type GPx4 (in the following referred to as 
wildtype, WT) or empty vector-tranduced cells (mock), were used as positive and negative 
controls, respectively. In addition, mutations of the remaining non-peroxidatic Cys residues 
were created whereby each Cys residue was replaced by a Ser individually (C2S, C10S, 
C37S, C66S, C75S, C107S, C148S, and C168S) or simultaneously as shown in Figure 10. 
 
 
Figure 10: Map showing the position of the Cys residues in mammalian GPx4. The 3D model of GPx4 was 
rotated and labelled to show the the positions of Cys (C2, C10, C37, C66, C75, C107, C148 and C168) using the 
human GPx4, which are labelled in yellow and the Sec (U46) which is labelled in red. Structural features are 
encoded as follows; α-helices in red, β-sheets in light green and flexible linker regions in violet other aa in grey. 
 
The two sets of substitutions were deemed necessary for two reasons: first, it was shown for 
the yeast homologue of GPx4, glutathione peroxidase 3 (yGPx3), that Cys 36 of yGPx3 is 
able to form a transient disulfide bridge with the peroxidatic Cys 598 of Yap1 during the 
GPx4 
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catalytic cycle of yGPx3 (Tolando, Jovanovic et al. 2000); second, invertebrates and 
terrestrial plants are practically devoid of Sec containing glutathione peroxidases, instead 
they express glutathione peroxidases that besides the redox active Cys (= peroxidatic Cys, 
CP) have an additional resolving Cys (CR). Upon oxidation of CP, the CR forms a transient 
disulfide-bridge with CP thereby releasing the reduced substrate. The intramolecular 
disulfide-bridge between the catalytically active Cys and the resolving Cys can be reduced by 
thioredoxin (Maiorino, Ursini et al. 2007).   
Finally, amino acids forming the proposed catalytic tetrad of GPx4 were included in these 
mutational studies (Figure 11) (Maiorino, Ursini et al. 2007).  
 
Figure 11: Map showing the position of the catalytic tetrade in mammalian GPx4. The 3D model of GPx4 
was rotated and labelled to show the catalytic tetrad of human GPx4 (U46, Q81, W136 and N137), which is 
labelled in red. Structural features are encoded as follows; α-helices in red, β-sheets in light green and flexible 
linker regions in violet other aa in grey. 
 
After the cloning of all constructs, lentiviruses were generated and used for transduction of 
the PFa1 cell line. 3-6 passages after lentiviral transduction, expression of the different 
constructs was studied by immunoblotting using an HA-specific antibody (Figure 12). This 
revealed that all variants, with the exception of the U46C and U46S, were expressed to 
almost even levels in the cells. An increase in protein level could be detected for U46C and 
U46S expressing cells that was about three times higher for the Cys variant and about six 
times higher for the Ser variant when compared with WT GPx4.  
 
GPx4 
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Figure 12: Expression of the mutants was determined by immunoblotting using an HA-specific antibody. 
β-Tubulin was used to assess loading of protein lysates. Below, expression efficiency was quantified as described 
in Materials and Methods (3.5.2). Expression of the individual mutants was normalized to β-Tubulin levels 
presented as fold increase/decrease compared with wild type GPx4 expression arbitrarily set as 1.  
 
Expression of the different GPx4 variants was monitored over a period of 50 passages in the 
absence of Tam using flow cytometry. As no additional selection pressure was imposed on 
lentivirus-infected cells, transfected cells were repeatedly analysed by measuring a 
fluorescent marker protein (VENUS) produced by the bi-cistronic GPx4 mRNA. Figure 13 
illustrates that exogenous GPx4 expression was stable for many passages in cell culture for 
WT GPx4 and U46C GPx4 expressing cells (Figure 13 A), as well as for all cysteine variants 
(Figure 13 B). Only expression of mock transduced cells and U46S transduced mutant form 
was gradually lost during subsequent passaging of cells (Figure 13 B), indicating that the 
expression of these forms does not provide growth advantage to the cells.  
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Figure 13: Stability of expression of the different GPx4 constructs in lentivirus-infected PFa1 cells. Cells 
were infected by lentiviruses with the indicated constructs. To be able to monitor infection efficiencies and stability 
of the constructs, expression was performed in a bi-cistronic manner using VENUS as a detectable marker. 
Expression was monitored by FACS analysis of VENUS-positive cells (FL1-H) after gating for living cells. (A) 
Cells carrying the WT, U46C, U46S GPx4 or mock construct. (B) Cells carrying the construct containing individual 
mutations of the non-peroxidatic Cys (C2S, C10S, C37S, C66S, C75S, C107S, C148S, C168S, respectively). 
Note that the WT and U46C expressing cells and all the individual non-peroxidatic Cys mutants, but not U46S and 
mock expressing cells, showed stable expression even after 25 and 50 passages without selective pressure. 
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4.1.2 The U46C mutant of GPx4 rescues GPx4 depleted cells from cell 
death 
 
To investigate whether the catalytically active Sec is essential for the supposedly vital role of 
GPx4 in cell survival and proliferation, cells expressing the different constructs (WT, U46C, 
U46S, mock and CxS’) were either treated with Tam to disrupt endogenous GPx4 expression 
or left untreated (control). For these analyses, freshly transduced cells (passage 3-6) were 
used to ensure that expression was still high in cells. Cell proliferation was monitored over a 
period of 60 hours (Figure 14 A and B, left panel). No significant differences in cell 
proliferation were detected between the different cell lines in the absence of the inducer. 
When cells were treated with Tam, parental, mock and U46S expressing cells died between 
36 and 48 hours after Tam administration (Figure 14 A, right panel). In stark contrast, U46C 
expressing cells survived like WT GPx4 expressing cells. No significant difference could be 
seen in the Cys to Ser variants (Figure 14 B right panel). 
 
Figure 14: The U46C mutant form of GPx4 rescues from cell death induced by endogenous GPx4 
disruption. (A, B, left panel) In the absence of Tam, cell proliferation was comparable between the different cell 
lines. (A, right panel) Unexpectedly, the U46C mutant was able to rescue cells from cell death induced by 
endogenous GPx4 disruption in a manner similar to WT GPx4 expressing cells. (B, right panel) None of the 
remaining Cys residues of GPx4 were required for the essential cell death inhibiting function of GPx4. PFa1 cells 
expressing the different constructs were treated with vehicle (0.07% EtOH; -Tam) or with Tam (+Tam) to disrupt 
endogenous GPx4. First measurement was set as 1. Shown is one representative experiment out of 2 
independent biological experiments (mean ± SD out of 6 technical replicas).  
 
This was unexpected and surprising as it was previously shown that the U46C variant of pig 
GPx4 has less than 1 ‰ activity compared to WT when analyzed in in vitro biochemical 
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assays (Maiorino, Aumann et al. 1995). When treated with Tam in order to induce deletion of 
the endogenous GPx4, all the eight Cys to Ser variants of GPx4 survived similar to WT GPx4 
expressing cells (Figure 14 B, right panel), suggesting that none of the remaining cysteines is 
essential for the rescuing effect of GPx4. 
 
 
4.1.3 Cells expressing the Sec/Cys mutant are equally resistant to stress 
conditions as WT expressing cells 
 
Since the U46C variant of GPx4 (and all other serine mutants of the non-peroxidatic 
cysteines) prevented cell death of GPx4 knockout cells, it was hypothesized that a difference 
in the rescuing activity between WT GPx4 and U46C (and the other Cys/Ser variants) may 
be unmasked when these cell lines are subjected to several stress inducing agents. 
Hydrogen peroxide (H2O2) and tert-Butyl hydroperoxide (tBOOH) were chosen since they are 
known to cause oxidative stress. Buthionine sulfoximine (BSO), a highly specific and 
irreversible inhibitor of the GSH synthesizing enzyme γ-glutamylcysteine synthetase (γ-
GCS), was used because it efficiently deprives cells from intracellular GSH. Doxorubicin 
intercalates into DNA, induces double strand breaks, and stabilises the topoisomerase II 
complex, thereby preventing DNA repair. 
As shown in Figure 15 A - D, the U46C variant was almost as effective as WT GPx4 in 
preventing cell death induced by treatment with BSO, H2O2, tBOOH or doxorubicin. Only 
when cells were treated with increasing concentrations of tBOOH, the U46C expressing cells 
appeared to be slightly less resistant (Figure 15 C). 
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Figure 15: U46C expressing cells are almost as stress-resistant as WT expressing cells. Upon Tam 
treatment, both cell lines were treated with increasing concentrations of (A) hydrogen peroxide (H2O2), (B) the γ-
glutamylcysteine-synthetase inhibitor L-buthionine sulfoximine (BSO), (C) tert-Butyl hydroperoxide (tBOOH) and 
(D) doxorubicin as indicated. 48 hours after treatment. First measurement was set as 1. Shown is one 
representative experiment out of 3 independent biological experiments (mean ± SD out of 6 technical replicas). 
Statistically significant results are marked with a star (p<0.05) and highly significant results with two stars 
(p<0.001). 
 
Like already observed for the U46C expressing cells, the different CxS variants of GPx4 
were almost as efficient as WT GPx4 expressing cells in protecting the cells from the 
different stress-inducing agents (Figure 16 A - D). An increase at low to medium 
concentrations of H2O2 is not surprising as it is known that such circumstances have a 
positive effect upon cell proliferation.  
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Figure 16: CxS expressing cells are as stress-resistant as WT expressing cells. Upon Tam treatment, all 
CxS expressing cell lines were treated with increasing concentrations of (A) hydrogen peroxide (H2O2), (B) the γ-
glutamylcysteine-synthetase inhibitor L-buthionine sulfoximine (BSO), (C) tert-butyl hydroperoxide (tBOOH) and 
(D) doxorubicin as indicated. 48 hours after treatment. First measurement was set as 1. Shown is one 
representative experiment out of 3 independent biological experiments (mean ± SD out of 6 technical replicas). 
No statistical differnces could be found. 
 
As a more “physiological” stress inducing condition, cells were exposed for 6 or 12 hours to 
either hypoxia (0.5 - 2 % O2) (Figure 17 A) or to hyperoxia (95 % O2) (Figure 17 B), 
respectively. Additionally, a combination of both conditions was used to mimic 
ischemia/reperfusion conditions. The first condition was a relatively short period for hypoxia 
(1 hour followed by 1 hour reperfusion with various oxygen levels (5 %, 20 %, and 95 %)) 
(Figure 17 C), whereas the second model used longer times for both, hypoxia (12 hours) and 
reperfusion (6 hours) (Figure 17 D); all experiments were conducted with 5 % CO2 and in the 
presence of Tam (Figure 17 A - D).  
The WT and U46C expressing cells showed an increased resistance to hyperoxia, probably 
due to the higher expression of the respective GPx4 variants compared to parental cell lines 
(Figure 17 B). Notably, cells overexpressing GPx4 also showed a higher tolerance for 
hypoxic conditions. Although it is still unclear whether hypoxia causes increased or 
decreased oxidative stress in cells, these results may indicate a yet unrecognized function of 
GPx4 during hypoxia.  
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Reoxygenation following hypoxic conditions is known to cause massive endogenous 
oxidative stress and cell death, for instance as observed in tissues and organs of stroke 
patients or patients suffering from cardiac infarction. Again, the U46C variant was as 
protective as WT GPx4 indicating that the U46C variant is as efficient as WT GPx4 at least 
with respect to these conditions (Figure 17 C - D). 
 
 
Figure 17: Resistance to hypoxia, hyperoxia and hypoxia/reoxygenation of GPx4-/- cells expressing WT or 
U46C GPx4. (A - D) PFa1 cells (parental) or PFa1 cells depleted of endogenous GPx4 by Tam but stably 
expressing WT GPx4 or U46C GPx4 were subjected to hypoxia or hyperoxia or hypoxia/reoxygenation for the 
time indicated.  Effects of 6 or 12 hours of (A) hypoxia or (B) hyperoxia. (C) Effect of 6 hours of hypoxia followed 
by 1 hour re-oxygenation (re) with the indicated concentrations of O2. (D) Effect of 12 hours of hypoxia followed 
by 6 hours re-oxygenation with the indicated concentrations of O2. First measurement was set as 1. Shown is one 
representative experiment out of 3 independent biological experiments (mean ± SD out of 6 technical replicas). 
Statistically significant results are marked with a star (p<0.05) and highly significant results with two stars 
(p<0.001). 
 
In order to test whether a prolonged exposure time to hypoxia and hyperoxia may be able to 
unveil differences between WT and U46C expressing cells, the different cell lines were 
subjected to either 24 hours of hypoxia, hyperoxia or 24 hours of hypoxia followed by 24 
hours of reperfusion under different oxygen levels (5 %, 20 % or 95 %). Normal culturing 
conditions (20 % oxygen) were used as control (Figure 18 A). No significant difference could 
be seen between the different cell lines under hypoxia or normal cell culture conditions. Only 
upon exposure to hyperoxic conditions a significant difference could be detected between the 
parental and WT or U46C overexpressing cells, respectively (Figure 18 A). When exposed to 
the prolonged hypoxia/reperfusion conditions, the WT overexpressing cells showed a 
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siginifcantly better survival under 5 % and 20 % oxygen when compared to the parental and 
U46C expressing cells. Yet no significant difference could be detected between WT and 
U46C overexpressing cells when subjected to 95 % oxygen conditions during reperfusion 
(Figure 18 B). 
 
Figure 18: Survival under hypoxia, hyperoxia and hypoxia/reoxygenation of GPx4-/- cells expressing WT 
or U46C GPx4 compared to parental cells. (A) PFa1 cells (parental) or PFa1 cells depleted of endogenous 
GPx4 by Tam but stably expressing WT GPx4 or U46C GPx4 were subjected to 24 hours hypoxia or hyperoxia or 
normal growth (20 % oxygen). (B) PFa1 cells (parental) or PFa1 cells depleted of endogenous GPx4 by Tam but 
stably expressing WT GPx4 or U46C GPx4 were subjected to 24 hours of hypoxia followed by 24 hours of 
reoxygenation with the indicated oxygen concentrations. First measurement was set as 1. Shown is one 
representative experiment out of 3 independent biological experiments (mean ± SD out of 6 technical replicas).  
Statistically significant results are marked with a star (p<0.05) and highly significant results with two stars 
(p<0.001). 
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4.1.4 Sec is incorporated at the UGA codon in WT GPx4 
 
Recent work by Lu et al. showed that under selenium-deficiency Cys instead of Sec is 
incorporated at the active site of the selenoprotein thioredoxin reductase 1 (Lu, Zhong et al. 
2009). To investigate the possibility that Cys instead of Sec may be incorporated at the UGA 
codon, which would also allow proliferation of GPx4-depleted cells, the SECIS element was 
deleted in the cDNAs coding for either WT GPx4 or U46C GPx4 (Figure 19 A). As expected 
no effect was observed in the absence of Tam (Figure 19 B). However, Tam treatment 
caused cell death of parental cells, mock-transfected cells and WT GPx4 expressing cells 
lacking the SECIS element (Figure 19 C), whereas the U46C expressing cells survived 
without the SECIS element. Thus, one can conclude that Cys is not incorporated at the UGA 
codon of WT GPx4 construct. The lack of protein expression for SECIS-less WT GPx4 was 
confirmed by immunoblotting using an HA-tag-specific antibody (Figure 19 D). 
Figure 19: The SECIS element is essential for the correct expression of WT GPx4, but not for the U46C 
variant. Recent studies indicated that under selenium deficiency, Cys instead of Sec is incorporated at the UGA 
codon of thioredoxin reductase 1. (A) To rule out that the rescuing effect of WT relies in part on Cys incorporation, 
the SECIS element was removed from both, the WT and the U46C variant. (B) In the absence of Tam, 
proliferation rates were comparable between all cell lines, ruling out any dominant negative effect of SECIS-less 
GPx4 variants. (C) Only the U46C mutant was able to rescue endogenous GPx4 deficiency while the SECIS-less 
WT GPx4 failed to do so. (D) Immunoblotting confirmed that no WT protein was expressed in the absence of the 
SECIS element. First measurement was set as 1. Shown is one representative experiment out of 2 independent 
biological experiments (mean ± SD out of 6 technical replicas).  
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4.1.5 Doxycycline inducible expression of WT and U46C variant in the 
GPx4 null background reveals decreased efficiency of U46C in 
rescuing cell death 
 
Intrigued by the finding that the U46C variant is almost as effective as WT GPx4 in rescuing 
cell death induced by the loss of endogenous GPx4, it was investigated whether it may be 
possible to detect differences in the rescuing effect when both variants are expressed at very 
low levels in a controllable manner. Therefore, both forms were cloned into the doxycycline 
(dox)-inducible pRTS1 expression vector (Bornkamm, Berens et al. 2005). Cells that showed 
stable expression were obtained after selection with hygromycin over 3 weeks. Following 
selection, cells were cultured in the presence of Tam and 1 ng/ml dox in order to guarantee 
cell survival. 
qRT-PCR analysis of dox-inducible WT and U46C expressing cells revealed that expression 
of both constructs could be increased depending on the amount of inducer (Figure 20 A). 
The low expression obtained in the absence of dox suggested that there was minimal 
leakiness, which, however, did not preclude the use of the system for the experimental 
question. Although mRNA levels could be detected by qRT-PCR (Figure 20 A), verification of 
protein expression proved to be elusive at 0.001 ng/ml dox, and even at 0.1 ng/ml only faint 
expression could be detected (Figure 20 B). 
As shown in Figure 20 C, as little as 0.001 ng/ml of dox was sufficient to allow proliferation of 
WT GPx4 expressing GPx4-/- cells. No further increase in proliferation was observed at 
higher dox concentrations (Figure 20 C, left panel). In U46C expressing cells, 0.001 ng/ml 
dox was also sufficient to allow proliferation of GPx4-deficient cells, although proliferation of 
U46C expressing cells was clearly reduced when compared to WT GPx4 expressing cells at 
the same concentration (Figure 20 C, right panel). In contrast to WT expressing cells, higher 
dox concentrations allowed an increase in the proliferation rate of U46C expressing cells. 
Only concentrations of 100 µg/ml dox and higher were toxic to the cells (data not shown). 
Therefore, it is tempting to speculate that minute amounts of WT GPx4 protein is sufficient to 
allow survival and proliferation of cells, whereas higher expression levels of WT GPx4 have 
an adverse impact upon proliferation. This may be due to reduced peroxide levels, which 
would otherwise stimulate proliferation. In contrast, higher amounts of U46C expression are 
required to reach a similar proliferation rate as WT GPx4 expressing cells, while a higher 
expression level of U46C in the respective cells does not impair cell proliferation in contrast 
to WT GPx4 expressing cells.  
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Figure 20: Expression and cell survival/proliferation of GPx4-/- cells expressing controllable amounts of 
WT or U46C. Tam-treated PFa1cells carrying the doxycycline (dox)-inducible pRTS1 expression vector 
(Bornkamm, Berens et al. 2005) containing WT or U46C were treated with the indicated amounts of dox. 
Expression was monitored by (A) quantitative RT-PCR (water was used as to check for primerdimerisation) and 
by (B) immunoblotting using the HA-tag specific antibody (PC = positive control, PFa1 cells stably expressing 
WT). (C) Changes in cell coverage of the well was measured in real time by the xCELLigence system (‘cell index’ 
is proportional to cell proliferation). Shown is one out of 2 independent experiments with similar results. 
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4.1.6 Only the (seleno)thiol in the catalytically active site is essential for 
the rescuing effect 
 
In addition to the catalytically important Sec, the short form of GPx4 contains eight other 
cysteine residues of yet unknown function. In 2002, Toledano and colleagues proposed a 
dual role for yGPx3, the homologue of GPx4: one corresponds to the “classical” peroxidising 
function, whereas the second is a redox-sensing function involving the formation of a 
disulfide bridge between the catalytically active Cys37, which corresponds to GPx4 Sec46, 
and the Cys82, which, has no corresponding Cys in mouse GPx4 (Delaunay, Pflieger et al. 
2002).  
To investigate whether one or several cysteine(s) besides the catalytic site Sec are essential 
for the rescuing effects, variants of WT GPx4 and U46C were generated, which lacked all 
cysteines but the catalytically important Sec/Cys of the active site (Figure 21 A). Two stably 
outgrowing clones were established, one for each cell line (allCys/Ser and allCys/SerU46C) 
(Figure 21 B).  
 
Figure 21: Expression of the allCys/Ser mutants was determined by immunoblotting using an HA-specific 
antibody. (A) Positions of the different Cys mutated to Ser in the allCys/Ser variants, allCys/Ser and 
allCys/SerU46C. (B) Protein expression was monitored using an HA-tag-specific antibody. β-Tubulin was used to 
assess similar loading of protein lysates. Below, expression efficiency was quantified as described in Materials 
and Methods (3.8.2). Expression of the individual mutants was normalized to β-Tubulin levels presented as fold 
increase/decrease compared with wild type GPx4 expression arbitrarily set as 1. 
 
As illustrated in Figure 22 no significant difference in cell proliferation rates could be detected 
between the different GPx4 variants in the absence of Tam (Figure 22 A, left panel). 
Interestingly, both cell lines rescued cell death induced by disruption of endogenous GPx4 
like that already observed for U46C GPx4 or of all mutants carrying single substitutions of the 
individual non-peroxidatic cysteine residues (Figure 22 A, right panel). Additional 
experiments with tBOOH as a stress inducing agent revealed a similar resistance of 
allCys/Ser and allCys/SerU46C to oxidative stress like WT GPx4 expressing cells (Figure 
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22 B). tBOOH was chosen as it was the only oxidative stress inducing agent, where a slight 
difference between WT and U46C could be detected (see also  Figure 15).  
 
 
Figure 22: Viability of GPx4+/+ and GPx4-/- cells stably expressing WT GPx4 or the allCys/Ser or 
allCys/SerU46C variants. (A) PFa1 cells, expressing mock, allCys/Ser and allCys/SerU46C in the absence (left 
panel) or presence (right panel) of Tam. In the absence of Tam no differences in proliferation could be observed 
(left). The allCys/Ser and allCys/SerU46C variants rescued cell death induced by GPx4 disruption (right). (B) 
allCys/Ser and allCys/SerU46C were subjected to oxidative stress triggered by tBOOH. First measurement was 
set as 1. Shown is one representative experiment out of 3 independent biological experiments (mean ± SD out of 
6 technical replicas). Statistically significant results are marked with a star (p<0.05) and highly significant results 
with two stars (p<0.001). 
 
Then, these cell lines (allCys/Ser and allCys/SerU46C overexpressing cells) were subjected 
to hypoxia, hyperoxia and hypoxia/reperfusion as performed already for WT and U46C 
overexpresssing cells (Figure 23 A). Similar to WT and U46C overexpressing cells, no 
significant difference could be observed between the different cell lines under hypoxia or 
normal cell culture condition. Only upon exposure to hyperoxic conditions a significant 
difference could be detected between the parental and allCys/Ser or allCys/SerU46C 
overexpressing cells (Figure 23 A). When exposed to the prolonged hypoxia/reperfusion 
model, the allCys/Ser overexpressing cells showed a better survival rate at 5 % oxygen 
tension compared to the parental and U46C expressing cells. Yet no significant difference 
could be detected between allCys/Ser and allCys/SerU46C expressing cells when subjected 
to 20 % or 95 % oxygen tension during the reperfusion phase (Figure 23 B). 
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Figure 23: Resistance to hypoxia, hyperoxia and hypoxia/reoxygenation of GPx4-/- cells expressing 
allCys/Ser or allCys/SerU46C GPx4 compared to parental cells. (A) PFa1 cells (parental) or PFa1 cells 
depleted of endogenous GPx4 by Tam but stably expressing allCys/Ser or allCys/SerU46C were subjected to 24 
hours hypoxia or hyperoxia or normal growth (20 % oxygen). (B) PFa1 cells (parental) or PFa1 cells depleted of 
endogenous GPx4 by Tam but stably expressing allCys/Ser or allCys/SerU46C were subjected to 24 hours of 
hypoxia followed by 24 hours of reoxygenation with the indicated oxygen concentrations. First measurement was 
set as 1. Shown is one representative experiment out of 2 independent biological experiments (mean ± SD out of 
6 technical replicas). Statistically significant results are marked with a star (p<0.05) and highly significant results 
with two stars (p<0.001). 
 
 
4.1.7 The Sec/Cys mutant shows decreased GPx4-specific activity 
compared to WT GPx4 
 
Previously, it was demonstrated that the U46C mutant of pig GPx4 has approximately 1000-
fold reduced GPx4-specific activity compared to wild type GPx4, when tested with the model 
substrate phosphatidylcholine hydroperoxide (PCOOH) in an in vitro glutathione peroxidase 
activity measurement (Maiorino, Aumann et al. 1995). Therefore, the specific GPx4 activity 
was investigated in crude lysates of cells expressing WT GPx4, U46C or U46S; mock-
transfected cells were used as negative control. Prior to analysis, the knockout of GPx4 was 
induced by Tam in all cell lines and 1 µm α-Toc was included in the medium to prevent cell 
death of U46S and mock-transfected cells due to depletion of endogenous GPx4. In fact, the 
U46C expressing cells showed a very small percentage of specific GPx4 activity when 
compared to WT expressing cells (Figure 24 A, left panel). The measured activity could not 
be unambiguously discriminated from the activity of the background controls (mock) and of 
U46S expressing cells, which is the enzymatically inactive form.  
The substitution of all non-catalytic Cys to Ser did not affect GPx4-specific activity (Figure 
24 B, right panel). Only when the catalytically active Sec was substituted by Cys the activity 
dropped again, as it did with the U46C variant (see Figure 24 A, left panel). Also, the relative 
expression of the allCys/SerU46C was about three times higher than that of WT or 
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allCys/Ser (Figure 24 B, right panel), as already observed for U46C (Figure 24 A, right 
panel). 
 
 
Figure 24: The Cys containing mutant variants of GPx4 do not show any detectable GPx4-specific activity 
when analysed in vitro. (A) Cell lysates from the different cell lines were subjected to the “classical” GPx4-
specific activity assay using phosphatidylcholine hydroperoxide as model substrate. Similar to what has been 
published for the Sec/Cys variant of pig GPx4 (Maiorino, Aumann et al. 1995), mouse U46C GPx4 showed a 
sharp drop in GPx4-specific activity compared to WT expressing cells, despite higher expression of the U46C 
variants ([au] stands for arbitrary units). (B) Although the allCys/Ser variant did not show a significant decrease in 
activity, the allCys/SerU46C variant again showed a significant drop in activity (left) and an increase in protein 
expression level (right). Shown is one out of 2 independent biological experiments (mean ± SD of 3 technical 
replicas). Statistically significant results are marked with a star (p<0.05) and highly significant results with two 
stars (p<0.001). 
 
From this it can be concluded, that despite a clear drop of GPx4 activity of the U46C variant, 
the U46C variant is able to sustain basic cell functions of GPx4-deficient cells, even when 
challenged with different stress conditions. 
 
 
 
 
 
 
 
 
___________________________________________________________________Results 
 
62 
4.2 Investigating the function of the long form of GPx4 
 
4.2.1 Generation and stable expression of the long form of GPx4 and 
mutant forms thereof in inducible GPx4-/- cells 
 
All of the above described experiments were performed with the cytosolic variant of GPx4 
(cGPx4), also called the short form of GPx4. To analyse whether the mitochondrial form of 
GPx4 (mGPx4), also called the long form, may rescue cell death induced by disruption of the 
endogenous GPx4 gene, a construct was generated, which included the N-terminal 
mitochondrial leader sequence (Mls) as an extension of the cytosolic GPx4. To this end, the 
Mls was cloned in front of the FSH-tagged GPx4 and the U46C variant, yielding mWT and 
mU46C, respectively. Furthermore, the Cys at position 16 in the Mls was replaced with a Ser, 
resulting in MlsC16S. The respective protein expression was verified by western blot 
analyses (Figure 25). Like previously observed, conversion of Sec to Cys caused a strong 
increase in expression while MlsC16S was similarly expressed as mGPx4 (Figure 25, mWT).  
 
Figure 25: Expression of MlsC16S, mWT and mU46C. (A) Shown is the corresponding position of the inserted 
mutation. The Mls is shown in red, the FSH-tag in black and the ORF of GPx4 in white. (B) Expression of the 
different mutants was determined by immunoblotting using an HA-specific antibody. α-Tubulin was used to assess 
protein loading. Below, expression efficiency was quantified as described in Materials and Methods (3.5.2). 
Expression of the individual mutants was normalized to β-Tubulin levels presented as fold increase/decrease 
compared with wild type GPx4 expression arbitrarily set as 1. 
 
To determine whether the Mls tag indeed conferred mitochondrial localisation, the 
localisation pattern of GPx4 was investigated by immuno-fluorescence and confocal laser 
microscopy (Figure 26). A co-localization study was conducted using Mitotracker red, and a 
rat GPx4-specific primary antibody visualized by means of a Cy5-conjugated α-rat, 
secondary antibody (fluorescing deep red). To ascertain that only reconstituted mGPx4 
protein will be detected, Pfa1 cells, expressing the different forms, were treated with Tam 
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prior to immuno-fluorescence analysis in order to deprive cells from endogenous GPx4. 
Following this, all cell lines were cultured in the presence of 1 µM α-Toc. The cells 
expressing the transduced GPx4 variants were recorded using the FITC-channel (Figure 26). 
As expected, no GPx4 signals could be detected in the parental cells after knockout 
induction, whereas GPx4 protein was detectable in all reconstituted cell lines.  
 
 
Figure 26: Subcellular localisation of GPx4 knockout cells expressing different GPx4 isoforms. Images 
were acquired using confocal laser microscopy. Mitochondria were stained with MitoTracker Red, GPx4 with a 
GPx4-specific antibody (1B4) that was detected by a secondary, Cy5-conjugated antibody (green). Nuclei were 
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counterstained with DAPI. Prior to analysis cells were treated with Tam to deplete cells from endogenous GPx4 
and cultured in the presence of 1 µM α-Toc to prevent cell death. As expected, no GPx4 immuno-reactivity was 
observed in the parental cells. Protein expression in cells expressing the U46C variants was clearly higher than 
that in WT expressing cells. Colocalization is seen as yellow in the merge. Background was substracted by 
Image J programand fake colours were added to greyscale phtoos for better visibility..  
 
Intriguingly, the cGPx4 could be detected in the cytosol as well as inside mitochondria. By 
contrast, localisation of mWT and mU46C was predominantly in mitochondria. However, 
when the Cys in the Mls was mutated to Ser, the localisation of MlsC16S changed and it was 
also detectable in the cytosol (Figure 26). 
 
 
4.2.2 Mitochondrial expression of GPx4 does not rescue GPx4 knockout 
cells from cell death  
 
Next, it was asked whether mGPx4 is capable of rescuing cell death induced by endogenous 
GPx4 deficiency. Previously it was shown by several groups that overexpression of mGPx4 
has an anti-apoptotic effect in cells and in transgenic mice (reviewed in (Conrad, Schneider 
et al. 2007; Conrad 2009)).  
In the absence of Tam, cell proliferation rates of the different variants were comparable 
between overexpressing cells and mock-transfected cell lines as well as parental cell lines 
(Figure 27 A). However, when endogenous GPx4 was disrupted by Tam treatment, only the 
MlsC16S variant was able to prevent cell death, whereas the mGPx4 and mU46C failed to 
rescue (Figure 27 B). This demonstrates that mitochondrial localisation of GPx4 is not 
sufficient to rescue cells from cell death and supports the idea that cytosolic localisation of 
GPx4 is prerequisite to prevent cell death induced by endogenous GPx4 disruption.  
 
Figure 27: Overexpression of the long form (= mitochondrial form) of GPx4 fails to prevent cell death 
induced by the disruption of endogenous GPx4. (A) In the absence of Tam, no significant difference in the 
proliferation rate could be detected. (B) Tam treatment revealed that neither mWT nor mU46C and only MlsC16S 
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was able to rescue the cells from cell death. First measurement was set as 1. Shown is one representative 
experiment out of 2 independent biological experiments (mean ± SD out of 6 technical replicas).  
 
Intrigued by these findings, the question arose whether the inability of mWT and mU46C to 
rescue the cells from cell death was due to its localisation inside mitochondria or to its 
insertion into sub-mitochondrial structures such as the outer membrane like a 
transmembrane protein. Due to a considerable amount of MlsC16S being localized in the 
cytosol, in silico prediction of a possible transmembrane domain (TMB) was performed using 
TMdas. This analysis revealed that the N-terminus of Mls-GPx4 seems to carry a 
transmembrane domain (Figure 28).  
Apparently, there are two possible explanations for this: i) substitution of the Cys to a Ser at 
this point is weakening the signal and seems to prevent an insertion of the MlsC16S into the 
mitochondrial membrane, thereby enabling it to rescue the otherwise lethal phenotype of 
GPx4 deletion, or ii) the substitution disrupts or at least impairs the ability of mGPx4 to be 
imported into mitochondria. 
 
Figure 28: Transmembrane domain (TMD) prediction using TMdas (http://www.sbc.su.se/~miklos/DAS/). A 
loose cut off for a possible TMD is set at 1.7 (dashed line), and a strict cut off is set at 2.2 (solid line). Results are 
shown for mWT on the left panel and MlsC16S on the right, indicating that the prediction value drops below the 
needed value to be a cognate TMD. 
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4.2.3 Overexpression of MlsC16S protects cells from oxygen induced 
cell death 
The stress model encompassing hypoxia, hyperoxia and hypoxia/reperfusion was applied to 
MlsC16S overexpressing cells (Figure 29 A). Interestingly, the MlsC16S variant showed a 
significantly decreased protection of cells under hypoxic and hyperoxic conditions, when 
compared to WT expressing cells, whereas no siginificant difference in survival could be 
detected during normal cell culture conditions (Figure 29 A). When exposed to the prolonged 
hypoxia/reperfusion model  the MlsC16S overexpressing cells showed a siginifcantly better 
survival when compared to parental cells only under 95 % oxygen, while no significant 
difference could be detected between WT and MlsC16S overexpressing cells under any of 
the investigated conditions (Figure 29 B). 
 
Figure 29: Resistance to hypoxia, hyperoxia and hypoxia/reoxygenation of GPx4-/- cells expressing 
MlsC16S compared to WT expressing cells. (A) PFa1 cells (parental) or PFa1 cells depleted of endogenous 
GPx4 by Tam but stably expressing WT or MlsC16S, respectively, were subjected to 24 hours hypoxia or 
hyperoxia or normal growth (20 % oxygen). (B) PFa1 cells (parental) or PFa1 cells depleted of endogenous GPx4 
by Tam but stably expressing WT or MlsC16S, respectively, were subjected to 24 hours of hypoxia followed by 24 
hours of reoxygenation for with the indicated oxygen concentrations. First measurement was set as 1. Shown is 
one representative experiment out of 2 independent biological experiments (mean ± SD out of 6 technical 
replicas). Statistically significant results are marked with a star (p<0.05) and highly significant results with two 
stars (p<0.001). 
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4.3 Addressing the cellular relevance of the remaining amino acids 
of the catalytic tetrad of GPx4 
 
Since Sec is part of a catalytic tetrad made up of U46, Q81, W136 and N137, it was 
interesting to see how the other three amino acids contribute to GPx4 catalysis, and thus to 
its rescuing function. In order to address this, five different variants were chosen in 
accordance with experiments previously performed by Maiorino‘s laboratory utilizing 
DmGPx4 variants (Tosatto, Bosello et al. 2008). The following substitutions were generated 
by site-directed PCR mutagenesis as outlined above: the uncharged polar glutamine (Q81) 
was replaced either by a charged polar, acidic amino acid (glutamic acid, Q81E), which 
represents an exchange with a similar amino acid or by a nonpolar Alanine (Q81A). The 
nonpolar tryptophan (W136) was substituted by the acidic, uncharged polar aspartic acid 
(W136D). Finally, the uncharged polar, amino acid of Asp (N137) was replaced either by a 
nonpolar alanine (N137A) or by an acidic, uncharged polar aspartic acid (N137D), which 
again represents an exchange with a similar amino acid (Figure 30 A). Protein levels were 
detected by immunoblot and estimated as described above. All the different variants showed 
expression levels similar to WT GPx4 (Figure 30 B).  
 
Figure 30: Expression of the mutants of the catalytic tetrad was determined by immunoblotting using an 
HA-specific antibody. (A) Positions of the different site-directed alterations in GPx4. (B) β-Tubulin was used to 
assess loading of protein lysates. Below, expression efficiency was quantified as described in Materials and 
Methods (3.5.2). Expression of the individual mutants was normalized to β-Tubulin levels presented as fold 
increase/decrease compared with wild type GPx4 expression arbitrarily set as 1. 
 
In the absence of Tam, cells expressing the different variants showed no significant 
difference in proliferation when compared to each other (Figure 31 A). However, when 
endogenous GPx4 expression was abolished by Tam, only the Q81E and N137A variants 
were able to prevent the cells from cell death, whereas Q81A, W136D and N137D failed to 
rescue (Figure 31 B). This indicates that the composition of the aminoacids of the catalytic 
tetrad (Figure 11) plays an important role in enzymatic activity. 
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Figure 31: Addressing the in vivo relevance of individual amino acids of the catalytic tetrad involved in 
GPx4 catalysis in cell survival and proliferation. (A) In the absence of Tam proliferation rates were 
comparable between all cell lines, ruling out any dominant negative effects. (B) Only the Q81E and N137A 
mutants were able to rescue endogenous GPx4 loss. First measurement was set as 1. Shown is one 
representative experiment out of 2 independent biological experiments (mean ± SD out of 6 technical replicas).  
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5 Discussion 
 
5.1 Elucidating the catalytic mechanisms of GPx4 in cells and mice 
 
5.1.1 A Cys variant of the wild type GPx4 selenoenzyme rescues cell 
death induced by GPx4 knockout despite non-detectable in vitro 
catalytic activity 
 
The conceptual basis for this work is built on three previous key findings concerning GPx4 
activity and function. Firstly, GPx4 is unique as its short (cytosolic) form is, so far, the only 
glutathione peroxidase, which has been shown to be essential for cell survival/proliferation 
and early mouse embryogenesis as well as neuronal development in newborn mice (Imai, 
Hirao et al. 2003, Yant, Ran et al. 2003, Seiler, Schneider et al. 2008, Wirth, Conrad et al. 
2010) By stark contrast, the nuclear and mitochondrial forms of GPx4 confer important 
functions only in sperm maturation (Pfeifer, Conrad et al. 2001, Conrad, Moreno et al. 2005, 
Schneider, Forster et al. 2009). Using tamoxifen-inducible GPx4 knockout cells (designated 
as PFa1 cells), it has been shown previously in our laboratory that the inducible depletion of 
endogenous GPx4 expression leads to an increase in 12/15-LOX activity and lipid 
hydroperoxide generation (Seiler, Schneider et al. 2008). In the same study it was also 
proposed that this ultimately causes apoptosis inducing factor (AIF)-mediated and caspase 
independent cell death. Cell death progression downstream of GPx4 inactivation could be 
interrupted either by inhibitors directed against 12/15-LOX, α-TOC or siRNA-mediated 
knockdown of AIF (Loscalzo 2008, Seiler, Schneider et al. 2008). Most recent data indicate 
that relocation of AIF from mitochondria to the nucleus requires truncation, and thus 
activation of the pro-apoptotic molecule Bid (Tobaben, Grohm et al. 2011). Secondly, it was 
shown, that the substitution of the Sec by Cys within the catalytically active centre of GPx4 
leads to a decrease of the protein activity by approximately three orders of magnitude 
(Maiorino, Aumann et al. 1995). Thirdly, it has been known that Cys-containing homologues 
of GPx4 do exist in other phyla like insects, plants or yeast. 
The findings and facts described above raised the fundamental question whether the 
complex incorporation of Sec into GPx4 is necessary for its function or whether specific 
alterations of the catalytic site are tolerated with respect to its rescuing activity. In order to 
shed light in this unsolved mystery, the Sec codon in GPx4 was substituted by either a Cys 
(U46C) or a Ser (U46S) codon. The Ser mutation served as a negative control as this mutant 
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does not have any catalytic activity due to its hydroxyl group instead of the seleno- or thiol-
group (Seiler, Schneider et al. 2008). All three mutated forms of GPx4 carried a FSH (Flag-
Strep-HA) tag at their N-termini (Gloeckner, Boldt et al. 2007), which would not only allow 
purification of yet-to-be identified binding partners/novel substrates of GPx4 but also the 
unambiguous detection of GPx4 in cells and tissues by immuno(histo)chemical means. A 
lenti-viral system was chosen to ensure high transduction efficiencies of the PFa1 cells as 
well as robust and stable expression of the different cGPx4 variants.  
To address a potentially rescuing capability of the respective cGPx4 variants, cells 
expressing the different forms were experimentally deprived of endogenous GPx4 
expression by conditional knockout of the floxed GPx4 gene by tamoxifen application. As 
expected, lentivirus-based reconstitution of WT expression was able to rescue the cells from 
cell death in contrast to the U46S variant, which failed to rescue the cells. Most surprisingly, 
the U46C variant was able to prevent cell death induced by endogenous GPx4 knockout like 
WT expressing cells. This finding was unexpected in light of a previous report by Maiorino 
and colleagues who showed by kinetic analysis of the purified pig GPx4 homologue, that a 
Sec/Cys substitution leads to an enzyme with an at least three orders of magnitude 
decreased catalytic efficiency, when measured in the classical GPx4-specific activity assay 
(Maiorino, Aumann et al. 1995). As observed in the study with purified pig GPx4 homologue 
(Maiorino, Aumann et al. 1995), the in vitro measured activity of PFa1 cells expressing the 
U46C mutant was also indistinguishable from background levels (Figure 24). Therefore, it 
remains obscure what the actual activity of the Sec/Cys mutant in intact cells is. It seems that 
despite its significantly decreased in vitro activity the U46C mutant enzyme still has sufficient 
activity in cells to prevent cell death and confers resistance to various stress inducing agents 
as discussed below. This indicates that the Cys mutant of GPx4 is particularly instable during 
experimental manipulations and/or during the activity assay, when it is susceptible to a 
possibly irreversible over-oxidation due to the oxidizing conditions in a cell-free system. This 
over-oxidation would lead to an inactivation of the enzyme and therefore calls for an 
optimised experimental procedure in order to prevent possible artefactual over-oxidation for 
instance during cell lysis or purification of heterologously expressed recombinant proteins. 
One solution to this technical limitation might be to perform these experiments under anoxic 
conditions.  
Another question that arises from these somehow unexpected findings on the Cys mutant of 
GPx4 is whether the biochemical measurements are indeed representative of the cellular 
mechanism required to protect the cells from cell death. At least two possibilities may be 
envisaged: firstly, the protection from cell death induced by lipid hydroperoxides results in an 
over-oxidised U46C variant which is subsequently degraded. Secondly, reduction of the 
oxidised U46C protein to its ground state is no longer achieved by two molecules of GSH 
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and therefore would be difficult to be determined by the classical GPx4-specific assay 
(Maiorino, Gregolin et al. 1990). A mixed disulfide (E-S-SG) will be barely resolved by a 
second GSH, however, it could be reduced by glutaredoxin (deglutathionylation) like any 
other glutathionylated protein (Holmgren 1979). Recently S-glutathionylation has been shown 
to be important in a number of critical oxidative signaling events and has been proposed to 
act as a biological switch (Xiong, Uys et al. 2011). It also influences protein structure/function 
and cellular regulatory events. Recently, increasing numbers of Cys-based redox switches 
are being found in many different regulatory and signalling systems (Spadaro, Yun et al. 
2010). It has also been shown, that S-glutathionylation is also involved in cell death 
signalling, as Fas becomes S-glutathionylated on Cys 294 in the death domain (Janssen-
Heininger, Aesif et al. 2010). S-glutathionylation of Fas does occur following degradation of 
Grx1 by caspases eight- and/or three. This promotes the recruitment of Fas into lipid rafts 
and assembly of the death inducing signalling complex (DISC). Importantly, overexpression 
of Grx1 attenuates Fas-induced apoptosis, while ablation of Grx1 increases the sensitivity of 
cells to undergo Fas-induced apoptosis. 
The results obtained from the cell culture experiments imply that, at least under normal in 
vitro cell culture conditions, the complex incorporation of Sec into GPx4 is dispensable and 
that at least a thiol group is essential for the rescuing effect. This is in line with the fact that 
other less complex organisms do not require a Sec residue in the GPx4 homologues in order 
to develop and survive (Diechtierow and Krauth-Siegel 2011). Moreover, it still remains 
unclear whether these findings are just representative for cellular studies or whether these 
findings can be translated into in an in vivo setting.   
 
 
5.1.2 Slight differences in the rescuing activity between WT and U46C 
GPx4 upon stress conditions 
 
To unravel a possible difference in oxidative stress susceptibility of cells expressing WT and 
the U46C variant, a series of cellular studies were conducted. To induce oxidative stress, WT 
and U46C expressing cells were exposed to BSO, H2O2, Doxorubicin or tBOOH. Additionally, 
cells were exposed to hypoxia, hyperoxia or conditions mimicking hypoxia/reperfusion for 
different time intervals as a more pathophysiological stress condition (Bunn and Poyton 
1996, Lee and Choi 2003, Freiberg, Krieg et al. 2006, Kulkarni, Kuppusamy et al. 2007). 
Thereby, it could be shown in this work that no difference could be detected between the 
cells expressing either the WT or U46C variant when exposed to different concentrations of 
BSO, H2O2 or Doxorubicin. Only the treatment of cells with low (0.5 µM) tBOOH 
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concentrations unraveled a difference in the rescuing activity. As an independent means to 
impose oxidative stress, cells were either kept under hypoxia, hyperoxia or 
hypoxia/reperfusion for different time periods. While no difference could be detected between 
the WT and U46C expressing cells during short (6 hours), medium (12 hours) or long (24 
hours) exposure to hypoxic or hyperoxic conditions, respectively, a difference could be 
unmasked by the hypoxia/reperfusion experiment. While the U46C form seemed to have a 
slight survival advantage during the shorter intervals of exposure, it became apparent that 
the WT form was able to protect the cells more efficiently during longer exposure times. This 
is in line with the biochemical findings, concerning the lower (hardly detectable) activity of 
U46C despite a higher expression level. While the cells expressing the U46C variant express 
approximately three-fold higher protein levels, which may confer protection for a short period 
of time, the higher activity of WT GPx4 is able to provide a survival advantage over a longer 
period towards chronic oxidative stress. This assumption seems to be reasonable, as the 
cells expressing the U46S variant fail to survive the knockout of endogenous GPx4, whereas 
the expression of the U46C variant allows for survival of cells under these conditions.   
 
 
5.1.3 The catalytically important tetrad is required for the rescuing effect 
of GPx4 and its variants 
 
In order to investigate the necessity of a catalytically active site in greater detail, a closer look 
was taken at the three remaining amino acids, Q81, W136 and N137, known to form the 
catalytic tetrad along with U46 (Flohe, Toppo et al. 2011). Therefore, the three amino acids 
were replaced by selected amino acids according to a report by Maiorino’s laboratory 
(Tosatto, Bosello et al. 2008) using site-directed mutagenesis of WT GPx4. This yielded 
Q81A, Q81E, W136D, N137A, and N137D, respectively. The substitutions were chosen in 
order to shift the pKa value of the Sec moiety towards more alkaline values. Additionally, the 
substitution of W136D removes the aromatic ring provided by Trp and is thereby able to 
perturb a possible electron shift between Sec and Trp. In line with the findings of Tosatto and 
colleagues (Tosatto, Bosello et al. 2008), the rescuing activity of GPx4 was fully abolished by 
the Q81A and N137D substitutions, which were shown to be inactive variants. The inability to 
rescue cells from cell death by these forms probably results from a change in the 
environment around the catalytically active Sec, which is an unfavourable condition for 
deprotonation by shifting the pKa value to a basic value (Maiorino et al., 1998). Thus, these 
alterations are considered to have an adverse impact on Sec deprotonation and thereby 
impair proper GPx4 function. It is also conceivable that the changes result in the inability to 
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reduce Sec back into its ground state by interfering with the ability of GSH to form a 
selenenyldisulfide. It is noteworthy to mention, that the N137A substitution, which rescued 
the cells, leads to a pKa of around 7.8 (Tosatto, Bosello et al. 2008), which is closer to the 
WT scenario (pKa of 7.2) than that of the N137D variant, which results in a pKa of around 
10.2. Only very low activity could be detected for the N137A variant, whereas no activity 
could be detected for the N137D form (Tosatto, Bosello et al. 2008). As the W136D mutation 
also proved to be lethal, further investigations including substitutions of Trp by phenylalanine 
(Phe) could be used to shed more light in a possible electron shift between Sec and Trp. This 
would also strengthen the idea that a lowered activity of GPx4 is sufficient to rescue cells 
form cell death caused by endogenous GPx4 depletion and prove that a catalytically active 
centre is crucial for the rescuing effect of the GPx4 variants. 
 
 
5.1.4  Inducible re-expression of WT and U46C GPx4 variants in GPx4 
knockout cells reveals a difference in rescuing function 
 
Intruiged by the higher protein expression of U46C variant in combination with the non-
detectable enzymatic activity it was decided to investigate whether the amount of GPx4 
expression could have an impact on survival/proliferation following disruption of endogenous 
GPx4. To achieve this, an expression system was established where the amount of WT or 
U46C expression could be tightly controlled by the inducer dox at sub-nanomolar levels 
(Bornkamm, Berens et al. 2005). A comparable expression of the mRNAs of the two different 
proteins, controlled by the amount of inducer, allowed unravelling that cells expressing the 
U46C construct require a higher expression level of mRNA and enzyme than WT expressing 
cells to obtain a survival effect and maximal proliferation (Figure 20). Interestingly, the level 
of mRNA expression required to produce the maximal effect on cell proliferation in WT 
expressing cells was detectable by qRT-PCR, yet at this condition GPx4 could not be 
detected at the protein level by immunoblotting. This probably mimics the condition of many 
somatic cells, where GPx4 is expressed at very low levels (Roveri, Maiorino et al. 1994). To 
obtain a comparable rescuing function, a larger amount of the Cys mutant is required and 
this corresponds reasonably well with the lower catalytic activity of the Cys- as compared to 
the Sec-containing enzyme in reducing hydroperoxides. 
Interestingly, higher expression levels of GPx4 proved to attenuate the proliferation rate in 
WT but not in U46C expressing cells. This may suggest that, besides its well established 
antiapoptotic function, wild-type GPx4 is involved in the control of cell cycle progression by 
the modulation of receptor tyrosine kinase signalling. It is a well established paradigm that 
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protein tyrosine phosphatases (PTPs) are regulated through reversible oxidation of the 
active-site cysteine by H2O2 (Boivin, Zhang et al. 2008; Boivin and Tonks 2010). The 
mechanism relies on the transient oxidation of the thiolate by H2O2 or other hydroperoxides 
(Gracanin and Davies 2007). In a recent report published by our group (Conrad, Sandin et al. 
2010), it was shown for the first time that the 12/15-LOX metabolic intermediate, 15-OOH-
eicosatetraenoic acid, a lipid hydroperoxide, is able to efficiently induce PTP oxidation at 
much lower concentration than H2O2, the classical inducer of PTP oxidation. Consequently, 
PDGF β-receptor specific phosphorylation was increased in GPx4 knockout cells due to 
increased oxidation of PTPs by lipid hydroperoxides. Hence, a higher expression of wild-type 
GPx4 may lead to lower peroxide levels in cells, and consequently to an increased steady-
state active stage of phosphatases with an adverse impact on proliferation. 
Unlike prevention of apoptosis, which among peroxidases is specific for GPx4, the function of 
attenuating the proliferation rate is shared with GPx1, a selenoperoxidase localized together 
with GPx4 in the cytosol and mitochondria of somatic cells (Handy, Lubos et al. 2009, Liang, 
Yoo et al. 2009). In view of the pivotal role of hydroperoxides in both survival and 
proliferation (D'Autreaux and Toledano, 2007; Schumacker, 2006), and the different 
substrate specificity of the two peroxidases, this observation might support the notion that 
survival and proliferation are controlled by different hydroperoxides of distinct chemical 
identity. For instance, membrane hydroperoxides, which are specific substrates of GPx4, are 
relevant for apoptosis (Seiler, Schneider et al. 2008), whereas small hydroperoxides 
including H2O2 and free fatty acid hydroperoxides, both common substrates of GPx1 and 
GPx4, are relevant for proliferation possibly through redox-regulated cell signalling  (Chen, 
Cai et al. 2006, Conrad, Sandin et al. 2010). Elucidation of the nature of the distinct oxidants 
involved in the plethora of the proliferative pathways is emerging a major challenge for the 
near future. This suggests that efficiency, in conjunction with expression level of WT GPx4, 
are key factors to properly regulate the balance between survival and proliferation of cells. 
 
 
5.1.5 The catalytic cycle of U46C does not involve a resolving Cys (CR) 
 
It has been known that the CysGPxs of invertebrates and plants which swiftly react with 
hydroperoxide carry a resolving Cys (CR) (Trujillo, Mauri et al. 2006, Hall, Karplus et al. 
2009). Therefore, it was an interesting hypothesis to see whether the U46C variant of GPx4 
may exploit a similar catalytic mechanism in order to remain in a functional state. 
To address this concept, a variant form of U46C was generated which lacks all but the 
catalytically active Cys (allCys/SerU46C). The corresponding form of WT (allCys/Ser) served 
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as control. Like WT GPx4, the allCys/Ser variant was able to rescue the cells from cell death 
induced by disruption of endogenous GPx4. The allCys/Ser form showed no significant 
difference in GPx4-specific activity or stress resistance when compared to WT. Likewise, the 
allCys/SerU46C variant behaved similarly to the U46C variant. This data provides conclusive 
evidence that none of the non-catalytical Cys residues is necessary for proper GPx4 activity 
in WT GPx4, nor for its rescuing activity. Hence, neither of the Cys residues is used as a 
default CR in the U46C variant.  
In conclusion, this set of data points towards a higher resistance of GPx4 against over-
oxidation when carrying a Sec in the active site. Yet it does not exclude the possibility that a 
CR would be favourable for full enzymatic activity in case of a Cys replacement in the active 
site (as it is found in the majority in non-vertebrate glutathione peroxidases), but it appears 
not to be essential for the ability of U46C to protect cells from cell death. Whether these non-
catalytic Cys residues might only play a role in forming the mitochondrial capsule by 
becoming cross-linked with other capsular proteins (Mauri 2005, Ursini Science 1999) or in 
chromatin condensation by forming disulfide bridges with protamines (Pfeifer FASEB 2001, 
Conrad MCB 2005) can only be addressed by generating mice expressing exclusively the 
WT (allCys/Ser) form.  
 
 
 
5.2 Cellular investigations concerning the long form of GPx4 
 
5.2.1 Expression of the long form of GPx4 fails to protect cells from cell 
death 
 
Previous work in our laboratory demonstrated that neither the mitochondrial (long) form 
(mGPx4) (Schneider, Forster et al. 2009), nor the nuclear form of GPx4 are required for 
embryogenesis and survival of mice (Conrad, Moreno et al. 2005). As this work has shown 
that the short form of GPx4 is able to protect the cells from cell death induced by disruption 
of endogenous GPx4, it was obvious to ask whether the long form (mGPX4) could provide a 
similar protective mechanism. In order to address this question, the WT and U46C variants of 
mGPx4 were cloned and expressed in PFa1 cells. Respective variants of the nuclear form 
were not investigated as it is only expressed in testis (Pfeifer, Conrad et al. 2001, Conrad, 
Moreno et al. 2005, Schneider, Vogt Weisenhorn et al. 2006). 
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As expected the expression of the mU46C variant was higher than that of mWT, which is 
consistent with the phenotype already observed for the short variants of WT and U46C. 
Interestingly, neither the WT nor the U46C variant of mGPX4 was able to protect the cells 
from cell death induced by inducible disruption of endogenous GPx4 expression. This is 
consistent with recent findings of Liang and collaborators, who showed that expression of the 
short form of GPx4 in transgenic mice promotes survival and normal development, whereas 
expression of the long form of GPx4 failed to rescue the lethal phenotype (Liang, Yoo et al. 
2009). The only obvious phenotype they showed in mice expressing the short form was male 
infertility (due to the lack of the mitochondrial form), which confirms findings by our groups 
(Schneider, Forster et al. 2009). These findings are compatible with two possibilities: (i) 
GPx4 exerts its cell death protecting function exclusively in the cytoplasm and not in 
mitochondria, or (ii) the short form is required for survival in the cytosol as well as in 
mitochondria. The later case implies that the short form lacking a mitochondrial localization 
sequence is imported into mitochondria through a yet unknown mechanism.  
 
 
5.2.2 The importance of subcellular localisation  
 
To furher corroborate the importance of the intracellular localization of GPx4 for protection 
against cell death, another form of GPx4 was designed which carries a substitution of Cys by 
Ser on position 16 of the Mls (MlsC16S). According to in silico analysis 
(http://www.sbc.su.se/~miklos/DAS/), this mutation would weaken a potential transmembrane 
domain positioned in the Mls. Co-localisation studies were conducted using confocal laser 
microscopy to determine the localisation of the different GPx4 variants. As expected the 
mGPx4 was found almost exclusively in mitochondria. By contrast, the MlsC16S variant was 
detected in mitochondria as well as in the cytosol. It is noteworthy in this context that the 
short form of GPx4 has also been found in the cytosol as well as in mitochondria. When 
deprived of endogenous GPx4, cells expressing the MlsC16S variant survived, as did the 
GPx4 expressing cells in contrast to mGPx4 expressing cells. This clearly indicates that the 
subcellular localisation (i.e. in the cytosol) of GPx4 determines its rescuing activity. However, 
it became obvious during hypoxia and hyperoxia experiments, that the cells expressing the 
MlsC16S form were less resistant than WT or U46C expressing cells. These results imply 
that the localisation the GPx4 is important for its full function. Liang et al. hypothesized that 
the rescuing effect of GPx4 is primarily due to its inner membrane localisation in 
mitochondria and its ability to repair cardiolipin (CL) peroxidation (Liang, Ran et al. 2009). CL 
is an important component of the inner mitochondrial membrane, where it constitutes about 
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20% of the total lipid composition. The only other place where cardiolipin can be found is in 
the membranes of most bacteria (Pangborn 1946). CL regulates aggregate structures and is 
believed to play a role in membrane fusion (Ortiz, Killian et al. 1999). Complex V of the 
oxidative phosphorylation machinery displays a high binding affinity for CL, binding four 
molecules of CL per molecule of complex V (Eble, Coleman et al. 1990). Recently it has 
been shown, that CL and horse cytochrome c can interact (Ascenzi, Polticelli et al. 2011) 
with either proapoptotic (i.e. catalysing lipid peroxidation), or antiapoptotic outcome (i.e. 
scavenging of peroxynitrite) by protecting mitochondria from reactive nitrogen and oxygen 
species (Ascenzi, Polticelli et al. 2011). An apoptotic chain of events is suggested, involving 
changes in cytochrome c phosphorylation, dephosphorylation being proapoptotic 
(Huttemann, Pecina et al. 2011), increased ROS levels via increased mitochondrial 
membrane potential, and oxidation of cardiolipin by cytochrome c followed by its release from 
the mitochondria (Kagan, Wipf et al. 2009, Huttemann, Pecina et al. 2011).  
Another finding points to a possible role of GPx4 in mitochondria. Upon deletion of the 
endogenous GPx4 gene cell death is mediated by translocation of AIF from mitochondria into 
the nucleus (Lorenzo, Susin et al. 1999, Susin, Lorenzo et al. 1999, Galluzzi, Joza et al. 
2008, Seiler, Schneider et al. 2008, Joza, Pospisilik et al. 2009, Norberg, Orrenius et al. 
2010, Sevrioukova 2011). Whether and how mitochondrially localised cGPx4 is involved in 
this cell death inducing mechanism remains to be studied.   
A putative role of the short form in mitochondria raised the question as to how the short form 
GPx4 is imported into mitochondria in the absence of a “classical” Mls-sequence. Several 
different mechanisms are known for the import and sorting of proteins in mitochondria. The 
classical one is guided by an N-terminal pre-sequence (Bolender, Sickmann et al. 2008), but 
there are also different forms of Mls-sequences for proteins anchored in the inner or outer 
mitochondrial membrane (Rapaport 2003). Interestingly, more than 50 % of the mitochondrial 
proteins do not use the classical pathway for their import into mitochondria (Bolender, 
Sickmann et al. 2008). One of the well described alternative pathways is the Mia40 – Erv1 
system, which is responsible for the import of proteins into the  intermembrane space (IMS) 
(Stojanovski, Muller et al. 2008). This system relies on certain characteristic motives in the 
target proteins such as CXC or CX9C (Hofmann, Rothbauer et al. 2005), which, however, are 
absent in GPx4. This import system functions basically by trapping imported proteins inside 
the IMS due to introduction of an intramolecular disulfide bond after their transit trough the 
outer mitochondrial membrane mediated by the transport outer membrane (TOM)-system 
(Stojanovski, Muller et al. 2008). As the Mia40 – Erv1 system relies on a redox cycle linked 
to the respiratory chain via cytochrome c, it was suggested that it could be used to sense 
oxygen levels in the cell. Thereby, it might act as a molecular switch that adapts the 
mitochondrial activities to cellular oxygen levels by affecting cytochrome c (Bihlmaier, 
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Mesecke et al. 2008). In this case the presence of GPx4 inside mitochondria as a freely 
moving molecule could have a regulatory effect upon this suggested molecular switch 
function by regulating mitochondrial ROS levels (Huttemann, Pecina et al. 2011).  
Moreover, recent studies conducted in Arabidopsis thaliana showed that mitochondrial 
carriers (MC) as part of mitochondrial carrier families (MCF) of inner membrane transporters 
can display a variety of different substrate specificities (Palmieri, Pierri et al. 2011). MCs are 
proteins from the solute carrier family which transfer molecules across the membranes of 
mitochondria (Nury, Dahout-Gonzalez et al. 2006). All MCs are encoded by nuclear genes. 
All carriers contain a common sequence, referred to as the MCF motif in each repeated 
region, with some variation in one or two signature sequences (Nury, Dahout-Gonzalez et al. 
2006). Further experiments are certainly necessary to investigate a possible involvement of 
GPx4 in the suggested Mia40-Erv1 pathway with special emphasis on how the Mls-less, 
short form of GPx4 actually translocates to mitochondria. 
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